<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">Phytomedicine</journal-id><journal-id journal-id-type="iso-abbrev">Phytomedicine</journal-id><journal-title-group><journal-title>Phytomedicine</journal-title></journal-title-group><issn pub-type="ppub">0944-7113</issn><issn pub-type="epub">1618-095X</issn><publisher><publisher-name>Published by Elsevier GmbH.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7840405</article-id><article-id pub-id-type="pii">S0944-7113(21)00018-0</article-id><article-id pub-id-type="doi">10.1016/j.phymed.2021.153476</article-id><article-id pub-id-type="publisher-id">153476</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Toxicity as prime selection criterion among SARS-active herbal medications</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name><surname>Oesch</surname><given-names>Franz</given-names></name><xref rid="aff0001" ref-type="aff">a</xref><xref rid="cor0001" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="au0002"><name><surname>Oesch-Bartlomowicz</surname><given-names>Barbara</given-names></name><xref rid="aff0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au0003"><name><surname>Efferth</surname><given-names>Thomas</given-names></name><xref rid="aff0003" ref-type="aff">c</xref></contrib><aff id="aff0001"><label>a</label>Institute of Toxicology, Johannes Gutenberg University, 55131 Mainz, Germany</aff><aff id="aff0002"><label>b</label>Oesch-Tox, Rheinblick 21, 55263 Ingelheim, Germany</aff><aff id="aff0003"><label>c</label>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, 55128, Mainz, Germany</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#x0204e;</label>Corresponding author. Institute of Toxicology, Johannes Gutenberg University, Obere Zahlbacherstr. 67, 55131 Mainz, Germany</corresp></author-notes><pub-date pub-type="pmc-release"><day>28</day><month>1</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>28</day><month>1</month><year>2021</year></pub-date><elocation-id>153476</elocation-id><history><date date-type="received"><day>30</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>10</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2021 Published by Elsevier GmbH.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder/><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0001"><p>We present here a new selection criterion for prioritizing research on efficacious drugs for the fight against COVID-19: the relative toxicity <italic>versus</italic> safety of herbal medications, which were effective against SARS in the 2002/2003 epidemic. We rank these medicines according to their toxicity <italic>versus</italic> safety as basis for preferential rapid research on their potential in the treatment of COVID-19. The data demonstrate that from toxicological information nothing speaks against immediate investigation on, followed by rapid implementation of <italic>Lonicera japonica, Morus alba, Forsythia suspensa,</italic> and <italic>Codonopsis</italic> spec. for treatment of COVID-19 patients. <italic>Glycyrrhiza</italic> spec. and <italic>Panax ginseng</italic> are ranked in second priority and ephedrine-free Herba Ephedrae extract in third priority (followed by several drugs in lower preferences). Rapid research on their efficacy in the therapy - as well as safety under the specific circumstances of COVID-19 - followed by equally rapid implementation will provide substantial advantages to Public Health including immediate availability, enlargement of medicinal possibilities, in cases where other means are not successful (non-responders), not tolerated (sensitive individuals) or just not available (as is presently the case) and thus minimize sufferings and save lives. Moreover, their moderate costs and convenient oral application are especially advantageous for underprivileged populations in developing countries.</p></abstract><kwd-group id="keys0001"><title>Keywords</title><kwd>COVID-19</kwd><kwd>Cytochrome P450, Phytochemicals</kwd><kwd>Rational phytotherapy</kwd><kwd>Public health</kwd><kwd>Toxicity</kwd></kwd-group><kwd-group id="keys0002"><title>Abbreviations</title><kwd>ACE2, angiotensin converting enzyme 2</kwd><kwd>COVID-19, Coronavirus disease 2019</kwd><kwd>CYP, cytochrome P450 monooxygenase</kwd><kwd>HIV-1, human immunodeficiency virus 1</kwd><kwd>IKK, inhibitor of &#x003ba;B kinase</kwd><kwd>JNK, c-Jun N-terminale kinase</kwd><kwd>MAPK, mitogen-activated protein kinase</kwd><kwd>NF-&#x003ba;B, nuclear factor- &#x003ba; B cells</kwd><kwd>NO, nitric oxide</kwd><kwd>SARS-CoV-2, severe acute respiratory syndrome coronavirus 2</kwd><kwd>SOD, superoxide dismutase</kwd><kwd>Th2, T helper cells, type 2</kwd></kwd-group></article-meta></front><body><sec id="sec0001"><title>Introduction and background</title><p id="para0001">All over the world researchers are engaged to rapidly find medications useful for the therapy of patients infected with the new coronavirus SARS-CoV-2 and/or for the prevention of COVID-19 (<xref rid="bib0042" ref-type="bibr">Hoffmann&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0091" ref-type="bibr">Magrone&#x000a0;et&#x000a0;al., 2020</xref>). The development of effective and safe vaccines is time-intensive due to several complication factors. A first problem arises by the mutability of the virus. SARS-CoV-2 possesses multiple mutations, which optimize binding properties to ACE2 as its receptor and the polybasic cleavage site in the viral spike protein (Anderson et&#x000a0;al., <xref rid="bib0004" ref-type="bibr">2020</xref>). Coronaviruses rapidly mutate by recombination (<xref rid="bib0058" ref-type="bibr">Kottier&#x000a0;et&#x000a0;al., 1995</xref>). Mutations of SARS-CoV-2 already led to several strains of SARS-CoV-2 (<xref rid="bib0141" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020</xref>). Vaccines should be able to deal with all of them as well as with future mutations. Therefore, relatively stable SARS-CoV-2 proteins should be identified as antigens to raise antibodies against SARS-CoV-2. In addition, vaccine-induced aggravation of infections by &#x0201c;antibody-dependent enhancement&#x0201d; (<xref rid="bib0088" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2018</xref>) should be avoided, as well as severe organ damage as observed with vaccines directed against SARS-CoV-1 in ferrets and mice (<xref rid="bib0139" ref-type="bibr">Tseng&#x000a0;et&#x000a0;al., 2012</xref>). Dealing with all these issues including the required trials predictably will demand quite some time.</p><p id="para0002">The time span to actual readiness of application is of obvious importance. Hence, medications already in clinical use and known for producing only few unwanted effects stand in front line. Thus, repurposing of drugs developed for other disease indications appears to be promising. At present, several such drugs are under clinical development, <italic>e.g.</italic> the Ebola drug remdesivir, the HIV drugs lopinavir and ritonavir and the antimalarial chloroquine (<xref rid="bib0017" ref-type="bibr">Costanzo&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0060" ref-type="bibr">Kumar&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0122" ref-type="bibr">Sanders&#x000a0;et&#x000a0;al., 2020</xref>). Unfortunately, their usefulness is hampered by as yet unknown effectivity (<italic>&#x0201c;The FDA has authorised remdesivir for use in COVID-19 patients: but there's no good evidence it reduces mortality&#x0201d;,</italic> Center for Evidence-Based Medicine, communication of May 12, 2020 <ext-link ext-link-type="uri" xlink:href="https://www.cebm.net/covid-19/the-fda-has-authorised-remdesivir-for-use-in-covid-19-patients-but-theres-no-good-evidence-it-reduces-mortality/" id="interref0001">https://www.cebm.net/covid-19/the-fda-has-authorised-remdesivir-for-use-in-covid-19-patients-but-theres-no-good-evidence-it-reduces-mortality/</ext-link>). Further drawbacks are technical inconveniences (such as the necessity of intravenous treatment of remdesivir) or quite massive adverse side effects, especially true for chloroquine.</p><p id="para0003">One treasury of rapidly available medications with acceptable side effects has been largely overlooked thus far: Some herbal remedies used since centuries in traditional medicine may be realistically promising to treat SARS-CoV-2-infected patients based on experiences made with SARS-CoV-infected patients during the 2002/2003 epidemic. These may, therefore, merit immediate, rigorous investigations. It is reasonable to hypothesize that chemical constituents in medicinal plants such as <italic>Lonicera japonica, Morus alba, Forsythia suspensa, Codonopsis</italic> spec., <italic>Glycyrrhiza</italic> spec., <italic>Panax ginseng</italic> which were useful for SARS therapy may also be useful to fight COVID-19.</p><p id="para0004">Undesirable effects of any drug obviously are essential limiting factors. Thus, the degree of toxicity may present a valuable basis for prioritizing urgently needed research on the rapid development of effective and sufficiently safe treatments for COVID-19 patients. This review presents published data regarding the toxicity of herbal medications from Far East traditional medicine, which have been reported to be useful for the therapy of SARS-CoV-1-infected patients during the first SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>). Irrespective of whether all these reports withstand rigorous scientific criteria, these herbal drugs are recommended by some physicians in despair and taken by some patients in despair, believing in their safety &#x0201c;as natural products&#x0201d; without knowledge of their respective safety or toxicity.</p><p id="para0005">In China more than 85% of SARS-CoV-2-infected patients received therapies from traditional Chinese medicine (<xref rid="bib0157" ref-type="bibr">Yang&#x000a0;et&#x000a0;al., 2020</xref>). It is of outstanding importance, therefore, to disseminate the knowledge on the safety <italic>versus</italic> toxicity of these drugs. Many of them may in fact have therapeutic or preventive potential for COVID-19. The relative safety or toxicity of them may represent a rational basis for prioritizing urgently needed, convincing research on potentially useful herbal drugs with a much longer experience than with relatively newly developed drugs. It is not impossible that some of the latter may lead to adverse effects, which do not become visible in controlled clinical trials, but only after a latency of several decades (as we painfully had to learn with many carcinogens). At present, we do not yet have remedies for immediate use for prevention or treatment of COVID-19. For the sake of the present patients and for attempting prevention of a possible second wave of infections, it is mandatory to keep an open mind to include into proper research all possible sources of medication which realistically promise to be effective for the prevention and/or cure of COVID-19, including herbal drugs used in traditional medicine. Several of them have been more recently investigated using rigorous scientific methods and criteria (<xref rid="bib0012" ref-type="bibr">Cheng&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0119" ref-type="bibr">Rai&#x000a0;et&#x000a0;al., 2017</xref>; <xref rid="bib0078" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2018</xref>). including analysis and structure elucidation of their constituents (<xref rid="bib0161" ref-type="bibr">Yu&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0133" ref-type="bibr">Sun&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0118" ref-type="bibr">Qu&#x000a0;et&#x000a0;al., 2020</xref>) as well as demanding quality control of preparations for use (<xref rid="bib0075" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2009</xref>; <xref rid="bib0038" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0032" ref-type="bibr">Gao&#x000a0;et&#x000a0;al., 2017</xref>). <italic>Lonicera japonica</italic> has proven to be a top candidate for COVID-19 therapy by virtual docking experiments on over 40,000 drugs showing their excellent binding capacity to critical target molecules of SARS-CoV-2 (spike protein, nucleocapsid protein, and 2&#x02019;-O-ribose methyltransferase) (<xref rid="bib0048" ref-type="bibr">Kadioglu&#x000a0;et&#x000a0;al., 2020</xref>). Glycyrrhizin has recently been shown to have the potential to bind to ACE2 (<xref rid="bib0120" ref-type="bibr">Ren&#x000a0;et&#x000a0;al., 2020</xref>), and Glycyrrhizic-acid-based carbon dots have been reported to show high antiviral activity by multisite inhibition mechanisms (<xref rid="bib0138" ref-type="bibr">Tong&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0006">The intention of this review article is to specifically provide an overview on published results on preclinical toxicity studies. Chinese medicine with its millennia-long experience follows holistic principles, <italic>i.e.</italic> the complexity of the human body is seen in its entirety. Hence, fighting diseases starts already with prevention and disease treatment attempts to restore the disease-causing imbalances in the whole body. This is achieved by influencing the meridians of the body, <italic>i.e.</italic> invisible channels connecting the organs and allowing body fluids to flow such as the life energy <italic>qi</italic> (<xref rid="bib0021" ref-type="bibr">Efferth,&#x000a0;2008</xref>). For intervention of meridians, external approaches are applied (<italic>e.g.</italic> acupuncture and moxibustion, massage, cupping, <italic>tai chi chuan etc.</italic>) and internal practices are used (<italic>e.g.</italic> complex herbal mixtures, meditation and others). By contrast, western academic medicine follows reductionistic approaches to reduce the complex diseases to its single disease causes and fight diseases by attacking single disease mechanisms.</p><p id="para0007">Drug development and marketing underlies strict rules and regulations to ensure safety and efficacy of new drugs. Like Western academic medicine, Chinese medicine also aims to apply efficient and safe medications. This is reached by bringing the right plant constituents together in herbal mixtures. In this context, the &#x0201c;emperor-minister-servant&#x0201d; principle is of interest. The &#x0201c;emperor&#x0201d; plant exerts the main pharmacological effect, the &#x0201c;minister plants&#x0201d; support the activity of the &#x0201c;emperor&#x0201d; plant, and the &#x0201c;servant&#x0201d; can reduce possible side effects and toxicities. During the past decades, Chinese medicine gained enormous interest in the Western world as a complement to academic Western medicine. If Chinese medicine should find its way to the European pharma-market, applicable laws for drug approval have to be followed which are valid for any drug &#x02013; being of synthetic or natural origin (<xref rid="bib0023" ref-type="bibr">Efferth&#x000a0;and Greten,&#x000a0;2012</xref>). Hence, the scientific investigation of pharmacological activity and toxic adverse effects of Chinese plants is of utmost importance to open the European market for Chinese herbal medicine. During the past two decades, we focused on both pharmacology and toxicology of Chinese herbs and their chemical constituents (<xref rid="bib0022" ref-type="bibr">Efferth&#x000a0;et&#x000a0;al., 2007</xref>; <xref rid="bib0057" ref-type="bibr">Konkimalla&#x000a0;and Efferth,&#x000a0;2008</xref>; <xref rid="bib0189" ref-type="bibr">Youns&#x000a0;et&#x000a0;al., 2010</xref>; <xref rid="bib0025" ref-type="bibr">Efferth&#x000a0;and Kaina,&#x000a0;2011</xref>; Quedraogo et&#x000a0;al, <xref rid="bib0110" ref-type="bibr">2012</xref>; <xref rid="bib0002" ref-type="bibr">Allard&#x000a0;et&#x000a0;al., 2013</xref>; <xref rid="bib0023" ref-type="bibr">Efferth&#x000a0;and Greten,&#x000a0;2012</xref>; <xref rid="bib0005" ref-type="bibr">Bhakta-Guha&#x000a0;and Efferth,&#x000a0;2017</xref>).</p><p id="para0008">In the present review, our intention is to give an overview on the toxicology of Chinese plants that may help to treat COVID-19. While specific reviews on the toxic effects are rare or even absent as of yet, a tremendous number of investigations on antivirally active Chinese plants to inhibit SARS-CoV-2 and to cure COVID-19 have been published in the year 2020 (Huang et&#x000a0;al., <xref rid="bib0045" ref-type="bibr">2020</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0073" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0157" ref-type="bibr">Yang&#x000a0;et&#x000a0;al., 2020</xref>). Therefore, in the present review we focused only on toxicology and refer the reader to the excellent reviews on the pharmacology of anti-COVID-19 Chinese plants and clinical trials performed with Chinese herbal medicine to treat this pandemic that appeared in parallel in this special issue of Phytomedicine (<xref rid="bib0043" ref-type="bibr">Hu&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0141" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0154" ref-type="bibr">Xia&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0163" ref-type="bibr">Zhang&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0166" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2020</xref>a; <xref rid="bib0165" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2020b</xref>; <xref rid="bib0168" ref-type="bibr">Zheng&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0009">Based on their already existing safety profile, the data presented here may provide a rational basis for ranking individual herbal medications for investigations on efficacy against COVID-19 (or, where the safety profile shows no concern, possibly even carefully controlled, immediate compassionate use). Potential advantages for patients&#x02019; welfare and Public Health benefit include: (1) Enlargement and diversification of pharmacological options where other drugs are not effective (non-responders), not tolerated (susceptible individuals) or not available (as is presently the case). (2) Convenient oral application by the patient himself without continuous necessity for professional assistance, and moderate costs, both of these especially advantageous for financially disadvantaged populations in developing countries. (3) Therapy optimization may become possible by using the presented information for complementary, synergistic or adjuvant combination treatment. (4) Finally and of basic importance, in cases where the pharmacological effect does not exceed placebo, the toxicological data presented in this review and the consequent selection of a non-toxic herbal drug will at least allow a psychological support without causing additional toxic effects.</p></sec><sec id="sec0002"><title><italic>Lonicera japonica</italic> (Flos Lonicerae Japonicae)</title><p id="para0010">
<italic>Lonicera japonica</italic> used since thousands of years belongs to the oldest drugs, and is one the most frequently prescribed drugs in Far East traditional medicine (<xref rid="bib0126" ref-type="bibr">Shang&#x000a0;et&#x000a0;al., 2011</xref>). Nowadays it is widely used also in cosmetics, soft drinks and health-oriented food (<xref rid="bib0126" ref-type="bibr">Shang&#x000a0;et&#x000a0;al., 2011</xref>; <xref rid="bib0076" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2019</xref>), thus possessing a large fundus of experience. <xref rid="bib0126" ref-type="bibr">Shang&#x000a0;et&#x000a0;al.&#x000a0;(2011)</xref> reviewed in detail the antiviral, antibacterial and antioxidative activities of <italic>Lonicera japonica</italic> as well as the isolation and characterization of more than 140 of its chemical constituents<italic>.</italic> Since then many further compounds were isolated from <italic>Lonicera japonica</italic> and characterized with respect to their pharmacological activities such as antiviral activities (<xref rid="bib0161" ref-type="bibr">Yu&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0020" ref-type="bibr">Ding&#x000a0;et&#x000a0;al., 2017</xref>; <xref rid="bib0078" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2018</xref>; <xref rid="bib0033" ref-type="bibr">Ge&#x000a0;et&#x000a0;al., 2019</xref>), suppression of inflammation-stimulating signaling pathways (<xref rid="bib0049" ref-type="bibr">Kang&#x000a0;et&#x000a0;al., 2010</xref>; <xref rid="bib0050" ref-type="bibr">Kao&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0062" ref-type="bibr">Kwon&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0066" ref-type="bibr">Lee&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0038" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0163" ref-type="bibr">Zhang&#x000a0;et&#x000a0;al., 2020</xref>) or terminal enzymes (<xref rid="bib0156" ref-type="bibr">Xu&#x000a0;et&#x000a0;al., 2007</xref>). As already stated in the Introduction, <italic>Lonicera japonica</italic> is one of the herbal medicines which were successfully used for the therapy of the SARS-CoV infected patients in the 2002/2003 SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0011">Regarding the scope of the present review <italic>Lonicera japonica</italic> (and <italic>Lonicera caerulea</italic>) did not lead to any toxicologically relevant changes in rats or mice tested up to high doses (<xref rid="bib0137" ref-type="bibr">Thanabhorn&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0086" ref-type="bibr">Lu&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0052" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0047" ref-type="bibr">Jeong&#x000a0;et&#x000a0;al., 2019</xref>). No cytotoxicity of polyphenols extracted from <italic>Lonicera japonica</italic> was observed at doses required for suppressing mediators of neurodegeneration released from lipopolysaccharide-treated microglia (interleukin-1&#x003b2;, tumor necrosis factor &#x003b1;, prostaglandin E2) (<xref rid="bib0038" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2016</xref>). <italic>Lonicera japonica</italic> has proven excellent binding properties for SARS-CoV-2 critical target molecules (spike protein, nucleocapsid protein, and 2&#x02019;-O-ribose methyltransferase) in virtual docking experiments using supervised machine learning (<xref rid="bib0048" ref-type="bibr">Kadioglu&#x000a0;et&#x000a0;al., 2020</xref>). Luteolin (the main flavonoid in <italic>Lonicera</italic>) binds with high affinity to the main protease of SARS-CoV-2. Interaction of luteolin with the main viral protease indicates its potential as antiviral molecule and is worthy of further investigations (<xref rid="bib0162" ref-type="bibr">Yu&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0012">From the toxicological point of view these findings taken together allow to rank <italic>Lonicera japonica</italic> for specific investigations on its potential to cure and/or prevent COVID-19 at high priority.</p></sec><sec id="sec0003"><title><italic>Morus alba</italic> (Folium Mori)</title><p id="para0013">
<italic>Morus alba</italic> has been used since a long time as fodder for animals and as food for humans providing much experience with its use. Antimicrobial, antioxidant, anti-diabetic, anti-hyperlipidemic, anti-atherosclerotic, anti-obesity, cardioprotective, and cognitive enhancement activities of Folium Mori have been reported (<xref rid="bib0007" ref-type="bibr">Chan&#x000a0;et&#x000a0;al., 2016</xref>). Furthermore, efficacy against airway inflammation (by interruption of NF-&#x003ba;B and JNK/c-Jun signaling) by the <italic>Morus</italic> constituent Moracin M (<xref rid="bib0068" ref-type="bibr">Lee&#x000a0;et&#x000a0;al., 2016</xref>) and inhibition of metalloproteinases were seen (<xref rid="bib0159" ref-type="bibr">Yiemwattana&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0150" ref-type="bibr">Wongwat&#x000a0;et&#x000a0;al., 2020</xref>). Specifically activity against human corona virus of Folium Mori has been observed (<xref rid="bib0136" ref-type="bibr">Thabti&#x000a0;et&#x000a0;al., 2020</xref>). As already stated in the Introduction section, <italic>Morus alba</italic> is one of the herbal medicines which were successfully used for the therapy of the SARS-CoV infected patients in the 2002/2003 SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0014">With respect to safety, the overwhelming majority of publications showed neither toxicity nor genotoxicity for <italic>Morus alba</italic> leaf, fruit or root extracts investigated <italic>in vitro</italic> as well as in rats and mice <italic>in vivo</italic> (<xref rid="bib0014" ref-type="bibr">Chichioco-Hernandez&#x000a0;et&#x000a0;al., 2011</xref>; <xref rid="bib0018" ref-type="bibr">De&#x000a0;Oliveira et&#x000a0;al., 2015</xref>; <xref rid="bib0019" ref-type="bibr">2016</xref>; <xref rid="bib0011" ref-type="bibr">Chang&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0094" ref-type="bibr">Marx&#x000a0;et&#x000a0;al., 2016</xref>;<xref rid="bib0153" ref-type="bibr">Wu&#x000a0;et&#x000a0;al., 2018</xref>; <xref rid="bib0160" ref-type="bibr">Yimam&#x000a0;et&#x000a0;al., 2018</xref>). One investigation showed several forms of damage, if mice were treated with an ethanol extract of <italic>Morus alba</italic> by the less physiological intraperitoneal route, but not after oral treatment (<xref rid="bib0018" ref-type="bibr">De&#x000a0;Oliveira et&#x000a0;al., 2015</xref>). A clinical study, comparing 25 patients topically treated with 75% mulberry extract oil with 25 placebo-treated individuals (<xref rid="bib0003" ref-type="bibr">Alvin&#x000a0;et&#x000a0;al., 2011</xref>) and another study on 45 participants with osteopenia perorally exposed to <italic>Morus alba</italic> and <italic>Polygonum odoratum</italic> leaves containing congee (rice mash) (<xref rid="bib0148" ref-type="bibr">Wattanathorn&#x000a0;et&#x000a0;al., 2018</xref>) observed clinical improvement, but no adverse effects.</p><p id="para0015">From the toxicological point of view these findings allow to rank <italic>Morus alba</italic> for specific investigations on its potential to prevent and/or cure COVID-19 at high priority.</p></sec><sec id="sec0004"><title><italic>Forsythia suspensa</italic> (Fructus Forsythiae)</title><p id="para0016">The aqueous extract of the fruit of <italic>Forsythia</italic> is widely used in traditional medicines against many frequently occurring disorders including inflammation, pain, fever, nausea, vomiting and abscess, leading to a rich treasure of information on its use (<xref rid="bib0146" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2018</xref>). Forsythoside A (<xref rid="bib0065" ref-type="bibr">Law&#x000a0;et&#x000a0;al., 2017</xref>; <xref rid="bib0169" ref-type="bibr">Zheng&#x000a0;et&#x000a0;al., 2019</xref>) and labdane diterpenoids (<xref rid="bib0155" ref-type="bibr">Xiang&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0166" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2020</xref>) isolated from the fruits of <italic>Forsythia suspensa</italic> showed antiviral activities and, as already stated in the Introduction, <italic>Forsythia</italic> is one of the herbal medicines, which were successfully used for the therapy of the SARS-CoV infected patients in the 2002/2003 SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0017">Studies in rats and mice on <italic>Forsythia</italic> and its major bioactive constituent forsythin did not show toxicities (<xref rid="bib0129" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0040" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2017</xref>). Several <italic>in vivo</italic> and <italic>in vitro</italic> tests showed no genotoxicity (<xref rid="bib0129" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0018">Phillyrin and forsythoside, important constituents of <italic>Forsythia suspensa</italic>, showed in rats <italic>(in vitro</italic> and <italic>in vivo)</italic> significant effects on CYP (cytochrome P450 monooxygenase) 1A2, CYP2C11, CYP2D1 and CYP3A1/2 (<xref rid="bib0013" ref-type="bibr">Cheng&#x000a0;et&#x000a0;al., 2017</xref>). Their human homologues are important for the metabolism of many clinically used drugs (<xref rid="bib0106" ref-type="bibr">Oesch-Bartlomowicz&#x000a0;and Oesch,&#x000a0;2007</xref>). Prior to the introduction of <italic>Forsythia</italic> or its constituents into clinical use, it should be clarified whether CYP interactions are relevant <italic>in vivo</italic> in human beings at the required doses. Except for this <italic>caveat</italic>, from the toxicological point of view the findings taken together allow to rank <italic>Forsythia suspensa</italic> for specific investigations on usefulness against COVID-19 at high priority.</p></sec><sec id="sec0005"><title><italic>Codonopsis</italic> spec. (Radix Codonopsicis)</title><p id="para0019">
<italic>Codonopsis</italic> has widely been used in traditional medicine for hematopoiesis improvement, regulation of gastrointestinal, endocrine and immune function (<xref rid="bib0041" ref-type="bibr">He&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0030" ref-type="bibr">Gao&#x000a0;et&#x000a0;al., 2018</xref>). <italic>Codonopsis lanceolata</italic> extract dampens allergic lung inflammation by inhibiting Th2 cell activation and augmenting mitochondrial superoxide dismutase (SOD2) expression (<xref rid="bib0124" ref-type="bibr">Seo&#x000a0;et&#x000a0;al., 2019</xref>). Lancemaside A from <italic>Codonopsis lanceolata</italic> prevents hypertension by inhibiting NADPH oxidase 2-mediated MAPK signaling and improving NO bioavailability (<xref rid="bib0132" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2019</xref>) and attenuates the inflammatory responses mediated by monocytes and macrophages by blocking the activation of inhibitor of &#x003ba;B kinase (IKK) and p65/NF-&#x003ba;B (<xref rid="bib0051" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2014</xref>). Phosphorylated <italic>Codonopsis pilulosa</italic> polysaccharide has been reported to inhibit duck hepatitis A virus replication (<xref rid="bib0098" ref-type="bibr">Ming&#x000a0;et&#x000a0;al., 2017</xref>). As already stated in the Introduction, <italic>Codonopsis</italic> is one of the herbal medicines which were successfully used for the therapy of the SARS-CoV infected patients in the 2002/2003 SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>). Moreover, <italic>Codonopsis</italic> has also been and still is used as food such as soup, wine and tea (<xref rid="bib0041" ref-type="bibr">He&#x000a0;et&#x000a0;al., 2015</xref>). Thus, there exists much experience with its use.</p><p id="para0020">
<italic>Codonopsis</italic> appears to have little toxicity (<xref rid="bib0030" ref-type="bibr">Gao&#x000a0;et&#x000a0;al., 2018</xref>). Studies in rats, rabbits and in patients on <italic>Codonopsis</italic> itself and on <italic>Codonopsis-</italic>containing medicinal mixtures did not reveal any marked toxicities (<xref rid="bib0001" ref-type="bibr">Ai&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0066" ref-type="bibr">Lee&#x000a0;et&#x000a0;al., 2015</xref>). Isolated constituents such as the saponin codonoposide showed practically no <italic>in vitro</italic> cytotoxicity (MTT assay) (<xref rid="bib0070" ref-type="bibr">Lee&#x000a0;et&#x000a0;al., 2002</xref>). Thus, investigations on the potential usefulness of <italic>Codonopsis</italic> for therapy or prevention of COVID-19 is recommended with high priority. <xref rid="bib0064" ref-type="bibr">Lau&#x000a0;et&#x000a0;al.&#x000a0;(2013)</xref> reported that <italic>Codonopsis tangshen</italic> herb extract inhibited CYP3A4 <italic>in vitro</italic>. This CYP is responsible for the metabolism of a vast array of clinically used drugs (<xref rid="bib0107" ref-type="bibr">Oesch-Bartlomowicz&#x000a0;et&#x000a0;al., 2001</xref>; <xref rid="bib0106" ref-type="bibr">Oesch-Bartlomowicz&#x000a0;and Oesch,&#x000a0;2007</xref>). This potentially important interaction should, therefore, be tested <italic>in vivo</italic> prior to a potential clinical use of <italic>Codonopsis</italic> in the fight against COVID-19<italic>.</italic> Except for this <italic>caveat,</italic> from the toxicological point of view the findings taken together allow to rank <italic>Codonopsis</italic> for specific investigations on its potential to cure and/or prevent COVID-19 at high priority.</p></sec><sec id="sec0006"><title><italic>Glycyrrhiza</italic> spec. / Radix et Rhizoma Glycyrrhizae</title><p id="para0021">
<italic>Glycyrrhiza</italic> (<italic>gancao</italic> in Chinese) (Radix et Rhizoma Glycyrrhizae) is among the most frequently used TMC drugs and <italic>licorice</italic> (root of <italic>Glycyrrhiza glabra, G. uralensis or G. inflata</italic>) is one of the worldwide most frequently used medicinal plants, well studied (<xref rid="bib0108" ref-type="bibr">Olukoga&#x000a0;and Donaldson,&#x000a0;2000</xref>; <xref rid="bib0028" ref-type="bibr">Fiore&#x000a0;et&#x000a0;al., 2005</xref>; <xref rid="bib0145" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2013</xref>
<xref rid="bib0102" ref-type="bibr">; National&#x000a0;Library of Medicine,&#x000a0;2018</xref>; <xref rid="bib0116" ref-type="bibr">Pastorino&#x000a0;et&#x000a0;al., 2018</xref>; <xref rid="bib0087" ref-type="bibr">Luis&#x000a0;et&#x000a0;al., 2018</xref>; <xref rid="bib0076" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0063" ref-type="bibr">Kwon&#x000a0;et&#x000a0;al., 2020</xref>; <xref rid="bib0141" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020</xref>), including research on antiviral activity (<xref rid="bib0140" ref-type="bibr">Utsunomiya&#x000a0;et&#x000a0;al., 1997</xref>; <xref rid="bib0117" ref-type="bibr">Pilcher,&#x000a0;2003</xref>; <xref rid="bib0027" ref-type="bibr">Fiore&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0133" ref-type="bibr">Sun&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>). Favorable effects include several actions which may offer relieve of COVID-19 symptoms such as downregulation of proinflammatory cytokines, reducing the accumulation of intracellular reactive oxygen species and reducing the hyperproduction of airway exudates (<xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>) as well as, most notably, binding to ACE2 (<xref rid="bib0059" ref-type="bibr">Kuhn&#x000a0;et&#x000a0;al., 2004</xref>). The <italic>guancao</italic> (Glycarrhizae Radix et Rhizoma) constituent Glyasperin F strongly binds to the ACE2 site 1 (grid3) and its constituent isorhamnetin binds strongly to the ACE2 site 2 (grid4) (<xref rid="bib0120" ref-type="bibr">Ren&#x000a0;et&#x000a0;al., 2020</xref>). Moreover, antiviral activity, elucidated mechanisms of which include sialylation of the hepatitis B virus surface antigen and inhibition of the fusion of HIV-1 membrane with cell membranes due to reduction of membrane fluidity have been reported (<xref rid="bib0027" ref-type="bibr">Fiore&#x000a0;et&#x000a0;al., 2008</xref>). The major licorice constituent glycyrrhizin interferes with H5N1 virus replication and H5N1-induced pro-inflammatory gene expression (<xref rid="bib0027" ref-type="bibr">Fiore&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0105" ref-type="bibr">Nishimoto et&#x000a0;al., 2010</xref>; <xref rid="bib0097" ref-type="bibr">Michaelis&#x000a0;et&#x000a0;al., 2011</xref>). Most worthy of note, glycyrrhizin had antiviral activity against the SARS coronavirus of the 2002/2003 epidemic, which was more effective in patients compared with several antiviral drugs (<xref rid="bib0015" ref-type="bibr">Cinatl&#x000a0;et&#x000a0;al., 2003</xref>). Moreover, <italic>licorice</italic> is widely used as sweetener and spice (<xref rid="bib0104" ref-type="bibr">Nazari&#x000a0;et&#x000a0;al., 2017</xref>) as well as thirst quencher (<xref rid="bib0109" ref-type="bibr">Omar&#x000a0;et&#x000a0;al., 2012</xref>). Therefore, rich experience is documented on its use.</p><p id="para0022">Chronic intake of high doses of &#x0201c;seemingly harmless&#x0201d; licorice in human subjects led to massive disturbance of the renin-angiotensin-aldosterone axis as apparent mineralocorticoid excess syndrome with increased Na<sup>+</sup> and water retention and K<sup>+</sup> loss, alkalosis, hypertension and edema (<xref rid="bib0104" ref-type="bibr">Nazari&#x000a0;et&#x000a0;al., 2017</xref>). Also, licorice's modest estrogenic activity (<xref rid="bib0061" ref-type="bibr">Kundu&#x000a0;et&#x000a0;al., 2018</xref>) and antithrombotic action (<xref rid="bib0029" ref-type="bibr">Francischetti&#x000a0;et&#x000a0;al., 1997</xref>; <xref rid="bib0096" ref-type="bibr">Mendes-silva&#x000a0;et&#x000a0;al., 2003</xref>) may lead to undesirable effects. However, in the latter case licorice as thrombin inhibitor (<xref rid="bib0029" ref-type="bibr">Francischetti&#x000a0;et&#x000a0;al., 1997</xref>; <xref rid="bib0096" ref-type="bibr">Mendes-silva&#x000a0;et&#x000a0;al., 2003</xref>) may have a beneficial influence on increased coagulation in COVID-19 patients (<xref rid="bib0135" ref-type="bibr">Tang&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0023">A considerable number of toxicity studies in animals gave non-uniform results tending to tolerable toxicities at moderate doses (<xref rid="bib0099" ref-type="bibr">Mirsalis&#x000a0;et&#x000a0;al., 1993</xref>; <xref rid="bib0101" ref-type="bibr">Nakagawa&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0128" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2008</xref>). The results of genotoxicity tests were in its majority negative (<xref rid="bib0046" ref-type="bibr">Isbrucker&#x000a0;and Burdock,&#x000a0;2006</xref>; <xref rid="bib0101" ref-type="bibr">Nakagawa&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0010" ref-type="bibr">Chandrasekaran&#x000a0;et&#x000a0;al., 2011</xref>). These results of toxicological investigations together with the wide and long-lasting experience with human use of licorice, apparently safe at moderate, non-chronic doses favor the recommendation of investigations on its usefulness for therapy or prevention of COVID-19 with relatively high priority. However, prior to its clinical use the occurrence of serious drug-drug interactions at the required doses should be excluded, a potential which appears realistic based on previous studies (<xref rid="bib0107" ref-type="bibr">Oesch-Bartlomowicz&#x000a0;et&#x000a0;al., 2001</xref>; <xref rid="bib0113" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2011</xref>; <xref rid="bib0076" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0141" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2020</xref>). Thus, except of this <italic>caveat,</italic> from the toxicological point of view the findings taken together recommend to rank <italic>Glycyrrhiza</italic> spec./Radix et Rhizoma Glycyrrhizae for specific investigations on its potential to cure and/or prevent COVID-19 at relatively high priority, followed by clinical application which should be carefully supervised on grounds on the somewhat unclear picture from the toxicological investigations.</p></sec><sec id="sec0007"><title><italic>Panax ginseng</italic> (Radix Panaci)</title><p id="para0024">Radix Panaci is a medicinal herb known in Eastern traditional medicine since ancient times and up to now for its reported anti-oxidative, anti-aging, anti-cancer and adaptogenic activities (<xref rid="bib0034" ref-type="bibr">Gillis,&#x000a0;1997</xref>; <xref rid="bib0016" ref-type="bibr">Coon&#x000a0;and Ernst,&#x000a0;2002</xref>; <xref rid="bib0100" ref-type="bibr">Murthy&#x000a0;et&#x000a0;al., 2018</xref>). The popularity of <italic>Panax ginseng</italic> in Western countries has been increasing for several reasons, including wide-spread attempts to restore or enhance vitality and wellness. All of this led to much experience with its use. Activities against a broad range of viruses were reported (<xref rid="bib0146" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2018</xref>). <italic>Panax ginseng</italic> is one of the herbal medicines which were successfully used for the therapy of the SARS-CoV infected patients in the 2002/2003 SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>).</p><p id="para0025">Several studies on potential toxic effects of <italic>Panax ginseng</italic> in rats and mice did not show any serious general toxicity (<xref rid="bib0112" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0115" ref-type="bibr">2013</xref>; <xref rid="bib0114" ref-type="bibr">2018</xref>; National Toxicology Program, <xref rid="bib0103" ref-type="bibr">2011</xref>, <xref rid="bib0130" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2014</xref>a) and studies on potential genotoxicities were negative (National Toxicology Program, <xref rid="bib0103" ref-type="bibr">2011</xref>; <xref rid="bib0130" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2014</xref>b). Clinical studies did not reveal serious treatment-related adverse effects (<xref rid="bib0072" ref-type="bibr">Lee&#x000a0;et&#x000a0;al., 2012</xref>; <xref rid="bib0127" ref-type="bibr">Shergis&#x000a0;et&#x000a0;al., 2013</xref>; <xref rid="bib0052" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0054" ref-type="bibr">2017</xref>). Use during pregnancy did not lead to adverse effects (<xref rid="bib0123" ref-type="bibr">Seely&#x000a0;et&#x000a0;al., 2008</xref>). No human data appear to exist concerning use during lactation, while minimal risks were seen in animal studies (Seely et&#x000a0;al., 2018). Special care needs to be taken against excessive doses (leading to problems including hypertension and spontaneous bleeding) as well as interactions with other drugs such as anticoagulants (<xref rid="bib0111" ref-type="bibr">Paik&#x000a0;and Lee,&#x000a0;2015</xref>).</p><p id="para0026">Use of <italic>Panax ginseng</italic> in mixtures with further components did not show any toxic effects in many cases. In few cases, where toxicities were observed, it was unclear which component(s) were responsible (<xref rid="bib0112" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2008</xref>; <xref rid="bib0124" ref-type="bibr">Seo&#x000a0;et&#x000a0;al., 2019</xref>).</p><p id="para0027">If individual components or metabolites of <italic>Panax ginseng</italic> were tested, some studies showed no toxicities (<xref rid="bib0130" ref-type="bibr">Shin&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0073" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2020</xref>) while others did (<xref rid="bib0073" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2020</xref>), especially embryotoxicities (<xref rid="bib0008" ref-type="bibr">Chan&#x000a0;et&#x000a0;al., 2004</xref>; <xref rid="bib0082" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2005</xref>; <xref rid="bib0044" ref-type="bibr">Huang&#x000a0;et&#x000a0;al., 2019</xref>). It is recommended to abstain from the respective preparations and even from <italic>Panax ginseng</italic> itself during the first trimester of pregnancy, until the safety is sufficiently established.</p><p id="para0028">Investigations on the potential usefulness of <italic>Panax ginseng</italic> in moderate, non-chronic doses for therapy/prevention of COVID-19 is, therefore, recommended (except during the first trimester of pregnancy). Apart from this <italic>caveat</italic>, from the toxicological point of view the findings taken together allow to rank <italic>Panax ginseng</italic> for specific investigations on its potential to cure and/or prevent COVID-19 at relatively high priority, followed by clinical application which should be carefully supervised on grounds on the somewhat unclear picture from the toxicological investigations.</p></sec><sec id="sec0008"><title><italic>Ephedra sinica</italic> (Herba Ephedrae)</title><p id="para0029">Herba Ephedrae (<xref rid="bib0071" ref-type="bibr">Lee,&#x000a0;2011</xref>) is used as commercial dietary supplement (<xref rid="bib0036" ref-type="bibr">Haller&#x000a0;et&#x000a0;al., 2004</xref>; <xref rid="bib0095" ref-type="bibr">Mehendale&#x000a0;et&#x000a0;al., 2004</xref>), especially for weight loss (<xref rid="bib0006" ref-type="bibr">Boozer&#x000a0;et&#x000a0;al., 2002</xref>). As already stated in the Introduction, <italic>Ephedra sinica</italic> is one of the herbal medicines from Traditional Chinese Medicine which were successfully used for the therapy of the SARS-CoV infected patients in the 2002/2003 SARS epidemic (<xref rid="bib0084" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0083" ref-type="bibr">2012a</xref>, <xref rid="bib0085" ref-type="bibr">2012b</xref>; <xref rid="bib0142" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0089" ref-type="bibr">Luo&#x000a0;et&#x000a0;al., 2020</xref>). The severity of toxic reactions to ephedra in comparisons to other botanical products has been described (<xref rid="bib0152" ref-type="bibr">Woolf&#x000a0;et&#x000a0;al., 2005</xref>). In animal experiments Herba Ephedrae damaged rat kidneys and salivary glands already at only moderately high doses (<xref rid="bib0037" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2018</xref>). Humans consuming dietary supplements containing <italic>Ephedra</italic> alkaloids experienced adverse cardiovascular and central nervous system events (<xref rid="bib0035" ref-type="bibr">Haller&#x000a0;and Benowitz,&#x000a0;2000</xref>). Use of Herba Ephedrae was associated with liver damage at low incidence (<xref rid="bib0151" ref-type="bibr">Woo&#x000a0;et&#x000a0;al., 2015</xref>). More frequently the use of Herba Ephedrae led to myocardial infarction, stroke and sudden death. These cardiovascular adverse effects did not depend on preexisting vascular or heart disease and did not only occur at massive doses, rather they were reported to have occurred within the manufacturer's dosing guidelines (<xref rid="bib0121" ref-type="bibr">Samenuk&#x000a0;et&#x000a0;al., 2002</xref>). This practically excludes Herba Ephedrae from being recommended for its usefulness against COVID-19. However, the anti-viral activity of Herba Ephedrae (<xref rid="bib0092" ref-type="bibr">Mantani&#x000a0;et&#x000a0;al., 1999</xref>; <xref rid="bib0149" ref-type="bibr">Wei&#x000a0;et&#x000a0;al., 2019</xref>) may be separable from the adverse effects. Hyuga et&#x000a0;al. developed and investigated an ephedrine-free Herba Ephedrae extract, which still exerted anti-influenza virus activity in a comparable manner as the full Herba Ephedrae extract, but without ephedrine-typical adverse effects (the ephedrine alkaloids in all likelihood being responsible for myocardial infarction, stroke and sudden death in Herba Ephedrae-treated patients) (<xref rid="bib0188" ref-type="bibr">Hyuga&#x000a0;et&#x000a0;al., 2016</xref>). From the toxicological point of view this processed, ephedrine-free Herba Ephedrae extract is interesting and is recommended for specific investigations on its usefulness to cure and/or prevent COVID-19 at medium to high priority, followed by clinical application which should be carefully supervised on grounds on the somewhat unclear picture from the toxicological investigations.</p></sec><sec id="sec0009"><title>Overall conclusions</title><p id="para0030">Several Far East traditional medicines, known for their wide range of pharmacological applications and at present also increasingly used in Western countries with the intention to promote health and improve wellness, had been reported as effective for SARS treatment during the 2002/2003 epidemic. Some of them have been characterized concerning their side effects and/or potential toxicities as discussed above. The available toxicological information allows to rank them as recommendable for immediate investigations on potential usefulness for treatment or prevention of COVID-19, followed by immediate implementation, at various priorities:<list list-type="simple" id="celist0001"><list-item id="celistitem0001"><label>&#x02022;</label><p id="para0031">High priority: Lonicera japonica, Morus alba, Forsythia suspensa, Codonopsis spec.</p></list-item><list-item id="celistitem0002"><label>&#x02022;</label><p id="para0032">Relatively high priority: Glycyrrhiza spec., Panax ginseng</p></list-item><list-item id="celistitem0003"><label>&#x02022;</label><p id="para0033">Medium to high priority: Ephedrine-free Herba Ephedrae extract</p></list-item></list>
</p><p id="para0034">Further possibilities not discussed in this publication are, on toxicological grounds, recommended at the following lower priorities, based on the review of the available literature by the authors of this publication:<list list-type="simple" id="celist0002"><list-item id="celistitem0004"><label>&#x02022;</label><p id="para0035">Intermediate priority: <italic>Astragalus membranaceus</italic> root, <italic>Eriobotrya</italic> japonica leaves, Galla chinensis, Scutellaria baicalensis root, <italic>Panax notoginseng</italic> root<italic>,</italic>
</p></list-item><list-item id="celistitem0005"><label>&#x02022;</label><p id="para0036">Relatively low priority: Chrysanthemum morifolium, <italic>Pinellia r</italic>hizome, <italic>Lithospermum erythrorhizon</italic> root</p></list-item><list-item id="celistitem0006"><label>&#x02022;</label><p id="para0037">Low priority: Prunus armeniaca seeds, <italic>Bupleurum chinense</italic> root</p></list-item><list-item id="celistitem0007"><label>&#x02022;</label><p id="para0038">Low priority at best: <italic>Angelica</italic> sinensis root, Toona sinensis, Gardenia jasminoides fruits, Pueraria lobata root</p></list-item></list>
</p><p id="para0039">We all hope for a medicinal cup to treat COVID-19 in the very near future. Possibilities include the development of vaccines as well as novel or repurposed synthetic drugs. Although hyped in public discussions, it is realistic to predict a substantial time until they will be a ready-to-use cup of remedy. However, between the cup and mouth is still time to die. We therefore strongly recommend rapid investigation of readily available herbal drugs, which were effective in the therapy of SARS, on their efficacy for the treatment of COVID-19 followed by immediate application in the treatment of COVID-19. As tool for prioritization of the needed research we recommend to use the priorities according to their relative toxicities <italic>versus</italic> safety as described in this review.</p><p id="para0040">The current emergency threatens the global public health with the tough reality, where no realistic chance should be overlooked or ignored on grounds of emotional prejudices.</p></sec><sec id="sec0010"><title>Author contribution statement</title><p id="para0041">FO, BOB and TE have equally contributed to the concept of this review. Contributions to writing were in the sequence FO, BO, TE. Critical review of the medical, toxicological and phytochemical aspects was by BO, FO and TE, respectively. All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="para0043">FO and BOB are members of Oesch-Tox Toxicological Consulting and Expert Opinions GmbH &#x00026; Co. KG, Ingelheim-Wackernheim, Germany. All three authors declare that the study was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>Q.</given-names></name><name><surname>Kim</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>D.B.</given-names></name></person-group><article-title>Post-marketing safety monitoring of shenqifuzheng injection: a solution made of <italic>dangshen</italic> (Radix Codonopsis) and <italic>huangqi</italic> (Radix Astragali Mongolici)</article-title><source>J. Tradit. Chin. Med.</source><volume>34</volume><year>2014</year><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">25185371</pub-id></element-citation></ref><ref id="bib0002"><element-citation publication-type="journal" id="sbref0002"><person-group person-group-type="author"><name><surname>Allard</surname><given-names>T.</given-names></name><name><surname>Wenner</surname><given-names>T.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Mechanisms of herb-induced nephrotoxicity</article-title><source>Curr. Med. Chem.</source><volume>20</volume><year>2013</year><fpage>2812</fpage><lpage>2819</lpage><pub-id pub-id-type="pmid">23597204</pub-id></element-citation></ref><ref id="bib0003"><element-citation publication-type="journal" id="sbref0003"><person-group person-group-type="author"><name><surname>Alvin</surname><given-names>G.</given-names></name><name><surname>Catambay</surname><given-names>N.</given-names></name><name><surname>Vergara</surname><given-names>A.</given-names></name><name><surname>Jamora</surname><given-names>M.J.</given-names></name></person-group><article-title>A comparative study of the safety and efficacy of 75% mulberry (<italic>Morus alba</italic>) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial</article-title><source>J. Drugs Dermatol.</source><volume>10</volume><year>2011</year><fpage>1025</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">22052272</pub-id></element-citation></ref><ref id="bib0004"><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>K.G.</given-names></name><name><surname>Rambaut</surname><given-names>A.</given-names></name><name><surname>Lipkin</surname><given-names>W.I.</given-names></name><name><surname>Holmes</surname><given-names>E.C.</given-names></name><name><surname>Garry</surname><given-names>R.F.</given-names></name></person-group><article-title>The proximal origin of SARS-CoV-2</article-title><source>Nat. Med.</source><volume>26</volume><year>2020</year><fpage>450</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">32284615</pub-id></element-citation></ref><ref id="bib0005"><element-citation publication-type="book" id="sbref0005"><person-group person-group-type="author"><name><surname>Bhakta-Guha</surname><given-names>D.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><chapter-title>Herbal medicines: Boon or bane for the human liver?</chapter-title><person-group person-group-type="editor"><name><surname>Hsin-Sheng Tsay</surname><given-names>HS</given-names></name><name><surname>Shyur</surname><given-names>LF</given-names></name><name><surname>Agrawal</surname><given-names>DC</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>SY</given-names></name></person-group><source>Medicinal Plants &#x02013; Recent Advances in Research and Development</source><year>2017</year><publisher-name>Springer international Publishing, 2017</publisher-name><fpage>469</fpage><lpage>491</lpage></element-citation></ref><ref id="bib0006"><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name><surname>Boozer</surname><given-names>C.N.</given-names></name><name><surname>Daly</surname><given-names>P.A.</given-names></name><name><surname>Homel</surname><given-names>P.</given-names></name></person-group><article-title>Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial</article-title><source>Int. J. Obes. Relat. Metab. Disord.</source><volume>26</volume><year>2002</year><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">12032741</pub-id></element-citation></ref><ref id="bib0007"><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>E.W.</given-names></name><name><surname>Lye</surname><given-names>P.Y.</given-names></name><name><surname>Wong</surname><given-names>S.K.</given-names></name></person-group><article-title>Phytochemistry, pharmacology, and clinical trials of <italic>Morus alba</italic></article-title><source>Chin. J. Nat. Med.</source><volume>14</volume><year>2016</year><fpage>17</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">26850343</pub-id></element-citation></ref><ref id="bib0008"><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>L.Y.</given-names></name><name><surname>Chiu</surname><given-names>P.Y.</given-names></name><name><surname>Lau</surname><given-names>T.K.</given-names></name></person-group><article-title>Embryotoxicity study of ginsenoside Rc and Re in <italic>in vitro</italic> rat whole embryo culture</article-title><source>Reprod. Toxicol.</source><volume>19</volume><year>2004</year><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">15336721</pub-id></element-citation></ref><ref id="bib0010"><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>C.V.</given-names></name><name><surname>Sundarajan</surname><given-names>K.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Srikanth</surname><given-names>H.S.</given-names></name><name><surname>Edwin</surname><given-names>J.</given-names></name><name><surname>Agarwal</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of the genotoxic potential of standardized extract of <italic>Glycyrrhiza glabra</italic> (GutGard&#x02122;)</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>61</volume><year>2011</year><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">22019788</pub-id></element-citation></ref><ref id="bib0011"><element-citation publication-type="journal" id="sbref0011"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>B.Y.</given-names></name><name><surname>Kim</surname><given-names>S.B.</given-names></name><name><surname>Lee</surname><given-names>M.K.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name></person-group><article-title>Nonclinical safety assessment of <italic>Morus alba</italic> L fruits: Study of 90-D toxicity in Sprague-Dawley rats and genotoxicity in Salmonella</article-title><source>J. Food Sci.</source><volume>81</volume><year>2016</year><fpage>T1328</fpage><lpage>T1335</lpage><pub-id pub-id-type="pmid">27075529</pub-id></element-citation></ref><ref id="bib0012"><element-citation publication-type="journal" id="sbref0012"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J.L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>Y.M.</given-names></name><name><surname>Wie</surname><given-names>C.L.</given-names></name><name><surname>Yang</surname><given-names>L.Q.</given-names></name><name><surname>Fu</surname><given-names>J.J.</given-names></name></person-group><article-title>Development of novel SCAR markers for genetic characterization of <italic>Lonicera japonica</italic> from high GC-RAMP-PCR and DNA cloning</article-title><source>Genet. Mol. Res.</source><year>2016</year><pub-id pub-id-type="doi">10.4238/gmr.15027737</pub-id></element-citation></ref><ref id="bib0013"><element-citation publication-type="journal" id="sbref0013"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name></person-group><article-title>Effects of phillyrin and frosynthoside A on rat cytochrome P450 activities <italic>in vivo</italic> and <italic>in vitro</italic></article-title><source>Xenobiotica</source><volume>47</volume><year>2017</year><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">27310729</pub-id></element-citation></ref><ref id="bib0014"><element-citation publication-type="journal" id="sbref0014"><person-group person-group-type="author"><name><surname>Chichioco-Hernandez</surname><given-names>C.</given-names></name><name><surname>Wudarski</surname><given-names>J.</given-names></name><name><surname>Gevaert</surname><given-names>L.</given-names></name><name><surname>Verschaeve</surname><given-names>L.</given-names></name></person-group><article-title>Evaluation of cytotoxicity and genotoxicity of some Philippine medicinal plants</article-title><source>Pharmacogn. Mag.</source><volume>7</volume><year>2011</year><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">21716927</pub-id></element-citation></ref><ref id="bib0015"><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Morgenstern</surname><given-names>B.</given-names></name><name><surname>Bauer</surname><given-names>G.</given-names></name><name><surname>Chandra</surname><given-names>P.</given-names></name><name><surname>Rabenau</surname><given-names>H.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name></person-group><article-title>Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus</article-title><source>Lancet</source><volume>361</volume><year>2003</year><fpage>2045</fpage><lpage>2046</lpage><pub-id pub-id-type="pmid">12814717</pub-id></element-citation></ref><ref id="bib0016"><element-citation publication-type="journal" id="sbref0016"><person-group person-group-type="author"><name><surname>Coon</surname><given-names>J.T.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title><italic>Panax ginseng</italic>: A systematic review of adverse effects and drug interactions</article-title><source>Drug Safety</source><volume>25</volume><year>2002</year><fpage>323</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">12020172</pub-id></element-citation></ref><ref id="bib0017"><element-citation publication-type="journal" id="sbref0017"><person-group person-group-type="author"><name><surname>Costanzo</surname><given-names>M.</given-names></name><name><surname>De Giglio</surname><given-names>M.</given-names></name><name><surname>Roviello</surname><given-names>G.N.</given-names></name></person-group><article-title>SARS-CoV-2: Recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, Hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus</article-title><source>Curr. Med. Chem.</source><year>2020</year><comment>(Advance online publication)</comment></element-citation></ref><ref id="bib0018"><element-citation publication-type="journal" id="sbref0018"><person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>A.M.</given-names></name><name><surname>Mesquita</surname><given-names>Mda.S.</given-names></name><name><surname>da Silva</surname><given-names>G.C.</given-names></name></person-group><article-title>Evaluation of toxicity and antimicrobial activity of an ethanolic extract from leaves of <italic>Morus alba</italic> L</article-title><source>Moraceae. Evid. Based Complement Alternat. Med.</source><year>2015</year><object-id pub-id-type="publisher-id">513978</object-id></element-citation></ref><ref id="bib0019"><element-citation publication-type="journal" id="sbref0019"><person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>A.M.</given-names></name><name><surname>Nascimento</surname><given-names>M.F.</given-names></name><name><surname>Ferreira</surname><given-names>M.R.</given-names></name></person-group><article-title>Evaluation of acute toxicity, genotoxicity and inhibitory effect on acute inflammation of an ethanol extract of <italic>Morus alba</italic> L. (Moraceae) in mice</article-title><source>J. Ethnopharmacol.</source><volume>194</volume><year>2016</year><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">27596329</pub-id></element-citation></ref><ref id="bib0020"><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name></person-group><article-title>Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase</article-title><source>Sci. Rep.</source><volume>7</volume><year>2017</year><fpage>45723</fpage><pub-id pub-id-type="pmid">28393840</pub-id></element-citation></ref><ref id="bib0021"><element-citation publication-type="book" id="sbref0021"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><chapter-title>Pharmaceutical biology of traditional Chinese medicine for cancer therapy</chapter-title><person-group person-group-type="editor"><name><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><source>Handbook of Ethnopharmacology</source><year>2008</year><publisher-name>Research Signpost</publisher-name><publisher-loc>Kerala, India</publisher-loc><fpage>105</fpage><lpage>128</lpage></element-citation></ref><ref id="bib0022"><element-citation publication-type="journal" id="sbref0022"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Fu</surname><given-names>Y.J.</given-names></name><name><surname>Zu</surname><given-names>Y.</given-names></name><name><surname>Schwarz</surname><given-names>G.</given-names></name><name><surname>Konkimalla</surname><given-names>V.B.</given-names></name><name><surname>Wink</surname><given-names>M.</given-names></name></person-group><article-title>Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine</article-title><source>Curr. Med. Chem.</source><volume>14</volume><year>2007</year><fpage>2024</fpage><lpage>2032</lpage><pub-id pub-id-type="pmid">17691944</pub-id></element-citation></ref><ref id="bib0023"><element-citation publication-type="journal" id="sbref0023"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Greten</surname><given-names>H.J.</given-names></name></person-group><article-title>Quality control for medicinal plants</article-title><source>Med. Aromat. Plants (Los Angeles)</source><volume>1</volume><year>2012</year><fpage>7</fpage></element-citation></ref><ref id="bib0025"><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Kaina</surname><given-names>B.</given-names></name></person-group><article-title>Herbal poisoning with emphasis to traditional Chinese medicine</article-title><source>Curr. Drug Metab.</source><volume>12</volume><year>2011</year><fpage>989</fpage><lpage>996</lpage><pub-id pub-id-type="pmid">21892916</pub-id></element-citation></ref><ref id="bib0027"><element-citation publication-type="journal" id="sbref0027"><person-group person-group-type="author"><name><surname>Fiore</surname><given-names>C.</given-names></name><name><surname>Eisenhut</surname><given-names>M.</given-names></name><name><surname>Krausse</surname><given-names>R.</given-names></name></person-group><article-title>Antiviral effects of <italic>Glycyrrhiza</italic> species</article-title><source>Phytother. Res.</source><volume>22</volume><year>2008</year><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">17886224</pub-id></element-citation></ref><ref id="bib0028"><element-citation publication-type="journal" id="sbref0028"><person-group person-group-type="author"><name><surname>Fiore</surname><given-names>C.</given-names></name><name><surname>Eisenhut</surname><given-names>M.</given-names></name><name><surname>Ragazzi</surname><given-names>E.</given-names></name><name><surname>Zanchin</surname><given-names>G.</given-names></name><name><surname>Armanini</surname><given-names>D.</given-names></name></person-group><article-title>A history of the therapeutic use of liquorice in Europe</article-title><source>J. Ethnopharmacol.</source><volume>99</volume><year>2005</year><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">15978760</pub-id></element-citation></ref><ref id="bib0029"><element-citation publication-type="journal" id="sbref0029"><person-group person-group-type="author"><name><surname>Francischetti</surname><given-names>I.M.</given-names></name><name><surname>Monteiro</surname><given-names>R.Q.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>J.A.</given-names></name></person-group><article-title>Identification of glycyrrhizin as a thrombin inhibitor</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>235</volume><year>1997</year><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">9196073</pub-id></element-citation></ref><ref id="bib0030"><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.M.</given-names></name><name><surname>Liu</surname><given-names>J.S.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name></person-group><article-title>Traditional uses, phytochemistry, pharmacology and toxicology of <italic>Codonopsis</italic>: a review</article-title><source>J. Ethnopharmacol.</source><volume>219</volume><year>2018</year><fpage>50</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">29501674</pub-id></element-citation></ref><ref id="bib0032"><element-citation publication-type="journal" id="sbref0032"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Derivative technology of DNA barcoding (nucleotide signature and SNP double peak methods) detects adulterants and substitution in Chinese patent medicines</article-title><source>Sci. Rep.</source><volume>7</volume><year>2017</year><fpage>5858</fpage><pub-id pub-id-type="pmid">28724933</pub-id></element-citation></ref><ref id="bib0033"><element-citation publication-type="journal" id="sbref0033"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Wan</surname><given-names>H.</given-names></name></person-group><article-title>Chemical constituents from <italic>Lonicera japonica</italic> flower buds and their anti-hepatoma and anti-HBV activities</article-title><source>Bioorg. Chem.</source><volume>92</volume><year>2019</year><object-id pub-id-type="publisher-id">103198</object-id></element-citation></ref><ref id="bib0034"><element-citation publication-type="journal" id="sbref0034"><person-group person-group-type="author"><name><surname>Gillis</surname><given-names>C.N.</given-names></name></person-group><article-title><italic>Panax ginseng</italic> pharmacology: a nitric oxide link?</article-title><source>Biochem. Pharmacol.</source><volume>54</volume><year>1997</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9296344</pub-id></element-citation></ref><ref id="bib0035"><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>C.A.</given-names></name><name><surname>Benowitz</surname><given-names>N.L.</given-names></name></person-group><article-title>Adverse cardiovascular and central nervous system events associated with dietary supplements containing <italic>Ephedra</italic> alkaloids</article-title><source>N. Engl. J. Med.</source><volume>343</volume><year>2000</year><fpage>1833</fpage><lpage>1838</lpage><pub-id pub-id-type="pmid">11117974</pub-id></element-citation></ref><ref id="bib0036"><element-citation publication-type="journal" id="sbref0036"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>C.A.</given-names></name><name><surname>Duan</surname><given-names>M.</given-names></name><name><surname>Benowitz</surname><given-names>N.L.</given-names></name><name><surname>Jacob</surname><given-names>P.</given-names><suffix>3rd.</suffix></name></person-group><article-title>Concentrations of <italic>Ephedra</italic> alkaloids and caffeine in commercial dietary supplements</article-title><source>J. Anal. Toxicol.</source><volume>28</volume><year>2004</year><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">15107143</pub-id></element-citation></ref><ref id="bib0037"><element-citation publication-type="journal" id="sbref0037"><person-group person-group-type="author"><name><surname>Han</surname><given-names>H.Y.</given-names></name><name><surname>Huh</surname><given-names>J.I.</given-names></name><name><surname>Han</surname><given-names>S.R.</given-names></name></person-group><article-title>Assessing the safety of an Ephedrae Herba aqueous extract in rats: A repeat dose toxicity study</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>94</volume><year>2018</year><fpage>144</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">29407176</pub-id></element-citation></ref><ref id="bib0038"><element-citation publication-type="journal" id="sbref0038"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Pang</surname><given-names>X.</given-names></name><name><surname>Liao</surname><given-names>B.</given-names></name><name><surname>Yao</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name></person-group><article-title>An authenticity survey of herbal medicines from markets in China using DNA barcoding</article-title><source>Sci. Rep.</source><volume>6</volume><year>2016</year><fpage>18723</fpage><pub-id pub-id-type="pmid">26740340</pub-id></element-citation></ref><ref id="bib0040"><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Z.</given-names></name><name><surname>Lei</surname><given-names>X.L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group><article-title>Evaluating the safety of forsynthin from <italic>Forsythia suspensa</italic> leaves by acute and sub-chronic oral administration in rodent models</article-title><source>Asian Pac. J. Trop. Med.</source><volume>10</volume><year>2017</year><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">28107864</pub-id></element-citation></ref><ref id="bib0041"><element-citation publication-type="journal" id="sbref0041"><person-group person-group-type="author"><name><surname>He</surname><given-names>J.Y.</given-names></name><name><surname>Ma</surname><given-names>N.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Komatsu</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Z.Y</given-names></name><name><surname>Fu</surname><given-names>W.M.</given-names></name></person-group><article-title>The genus <italic>Codonopsis</italic> (Campanulaceae): a review of phytochemistry, bioactivity and quality control</article-title><source>J. Nat. Med.</source><volume>69</volume><year>2015</year><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">25099952</pub-id></element-citation></ref><ref id="bib0042"><element-citation publication-type="journal" id="sbref0042"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Kleine-Weber</surname><given-names>H.</given-names></name><name><surname>Schroeder</surname><given-names>S.</given-names></name></person-group><article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">32142651</pub-id></element-citation></ref><ref id="bib0043"><element-citation publication-type="journal" id="sbref0043"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Guan</surname><given-names>W.J.</given-names></name><name><surname>Bi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Duan</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Ruan</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>Z.H.</given-names></name><name><surname>Zhong</surname><given-names>N.S.</given-names></name></person-group><article-title>Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial</article-title><source>Phytomedicine</source><year>2020</year><object-id pub-id-type="publisher-id">153242</object-id></element-citation></ref><ref id="bib0044"><element-citation publication-type="journal" id="sbref0044"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.H.</given-names></name><name><surname>Wang</surname><given-names>F.T.</given-names></name><name><surname>Chan</surname><given-names>W.H.</given-names></name></person-group><article-title>Dosage-related beneficial and deleterious effects of ginsenoside Rb1 on mouse oocyte maturation and fertilization and fetal development</article-title><source>Environ. Toxicol.</source><volume>34</volume><year>2019</year><fpage>1001</fpage><lpage>1012</lpage><pub-id pub-id-type="pmid">31112002</pub-id></element-citation></ref><ref id="bib0045"><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.F.</given-names></name><name><surname>Bai</surname><given-names>C.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name></person-group><article-title>Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)</article-title><source>Pharmacol. Res.</source><volume>158</volume><year>2020</year><object-id pub-id-type="publisher-id">104939</object-id></element-citation></ref><ref id="bib0188"><element-citation publication-type="journal" id="sbref0046"><person-group person-group-type="author"><name><surname>Hyuga</surname><given-names>S.</given-names></name><name><surname>Hyuga</surname><given-names>M.</given-names></name><name><surname>Oshima</surname><given-names>N.</given-names></name></person-group><article-title>Ephedrine alkaloids-free <italic>Ephedra</italic> Herb extract: A safer alternative to <italic>Ephedra</italic> with comparable analgesic, anticancer, and anti-influenza activities</article-title><source>J. Nat. Med.</source><volume>70</volume><year>2016</year><fpage>571</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">26943796</pub-id></element-citation></ref><ref id="bib0046"><element-citation publication-type="journal" id="sbref0047"><person-group person-group-type="author"><name><surname>Isbrucker</surname><given-names>R.A.</given-names></name><name><surname>Burdock</surname><given-names>G.A.</given-names></name></person-group><article-title>Risk and safety assessment on the consumption of Licorice root (<italic>Glycyrrhiza</italic> sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>46</volume><year>2006</year><fpage>167</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">16884839</pub-id></element-citation></ref><ref id="bib0047"><element-citation publication-type="journal" id="sbref0048"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>J.</given-names></name><name><surname>Bae</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group><article-title>A 13-week repeated oral dose toxicity study of ChondroT in Sprague-Dawley rats</article-title><source>BMC Complement. Altern. Med.</source><volume>19</volume><year>2019</year><fpage>367</fpage><pub-id pub-id-type="pmid">31830971</pub-id></element-citation></ref><ref id="bib0048"><element-citation publication-type="journal" id="sbref0049"><person-group person-group-type="author"><name><surname>Kadioglu</surname><given-names>O.</given-names></name><name><surname>Saeed</surname><given-names>M.</given-names></name><name><surname>Greten</surname><given-names>H.J.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning</article-title><source>Bull. WHO</source><year>2020</year><pub-id pub-id-type="doi">10.2471/BLT.20.255943</pub-id></element-citation></ref><ref id="bib0049"><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>O.H.</given-names></name><name><surname>Choi</surname><given-names>J.G.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kwon</surname><given-names>D.Y.</given-names></name></person-group><article-title>Luteolin isolated from the flowers of <italic>Lonicera japonica</italic> suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells</article-title><source>Molecules</source><volume>15</volume><year>2010</year><fpage>385</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">20110898</pub-id></element-citation></ref><ref id="bib0050"><element-citation publication-type="journal" id="sbref0051"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>S.T.</given-names></name><name><surname>Liu</surname><given-names>C.J.</given-names></name><name><surname>Yeh</surname><given-names>C.C.</given-names></name></person-group><article-title>Protective and immunomodulatory effect of flos Lonicerae japonicae by augmenting IL-10 expression in a murine model of acute lung inflammation</article-title><source>J. Ethnopharmaco</source><volume>l168</volume><year>2015</year><fpage>108</fpage><lpage>115</lpage></element-citation></ref><ref id="bib0051"><element-citation publication-type="journal" id="sbref0052"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Yang</surname><given-names>W.S.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name></person-group><article-title>Lancemaside A from <italic>Codonopsis lanceolata</italic> modulates the inflammatory responses mediated by monocytes and macrophages</article-title><source>Mediators Inflamm.</source><volume>2014</volume><year>2014</year><object-id pub-id-type="publisher-id">405158</object-id></element-citation></ref><ref id="bib0052"><element-citation publication-type="journal" id="sbref0053"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Park</surname><given-names>S.I.</given-names></name><name><surname>Choi</surname><given-names>S.H.</given-names></name></person-group><article-title>Single oral dose toxicity test of blue honeysuckle concentrate in mice</article-title><source>Toxicol. Res.</source><volume>31</volume><year>2015</year><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">25874034</pub-id></element-citation></ref><ref id="bib0054"><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>M.K.</given-names></name><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>Kwon</surname><given-names>B.S.</given-names></name><name><surname>Suh</surname><given-names>D.H.</given-names></name><name><surname>Song</surname><given-names>Y.S.</given-names></name></person-group><article-title>Effect of red ginseng on genotoxicity and health-related quality of life after adjuvant chemotherapy in patients with epithelial ovarian cancer: A randomized, double-blind, placebo-controlled trial</article-title><source>Nutrients</source><volume>9</volume><year>2017</year><fpage>E772</fpage><pub-id pub-id-type="pmid">28753932</pub-id></element-citation></ref><ref id="bib0057"><element-citation publication-type="journal" id="sbref0058"><person-group person-group-type="author"><name><surname>Konkimalla</surname><given-names>V.B.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Evidence-based Chinese medicine for cancer therapy</article-title><source>J. Ethnopharmacol.</source><volume>116</volume><year>2008</year><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">18243610</pub-id></element-citation></ref><ref id="bib0058"><element-citation publication-type="journal" id="sbref0059"><person-group person-group-type="author"><name><surname>Kottier</surname><given-names>S.A.</given-names></name><name><surname>Cavanagh</surname><given-names>D.</given-names></name><name><surname>Britton</surname><given-names>P.</given-names></name></person-group><article-title>Experimental evidence of recombination in coronavirus infectious bronchitis virus</article-title><source>Virology</source><volume>213</volume><year>1995</year><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">7491781</pub-id></element-citation></ref><ref id="bib0059"><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>J.H.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Choe</surname><given-names>H.</given-names></name><name><surname>Farzan</surname><given-names>M.</given-names></name></person-group><article-title>Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus</article-title><source>Cell. Mol. Life Sci.</source><volume>61</volume><year>2004</year><fpage>2738</fpage><lpage>2743</lpage><pub-id pub-id-type="pmid">15549175</pub-id></element-citation></ref><ref id="bib0060"><element-citation publication-type="journal" id="sbref0061"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Harilal</surname><given-names>S.</given-names></name><name><surname>Al-Sehemi</surname><given-names>A.G.</given-names></name><name><surname>Mathew</surname><given-names>G.E.</given-names></name><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Mathew</surname><given-names>B.</given-names></name></person-group><article-title>The chronicle of COVID-19: possible strategies to curb the pandemic</article-title><source>Curr. Med. Chem.</source><year>2020</year><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="bib0061"><element-citation publication-type="journal" id="sbref0062"><person-group person-group-type="author"><name><surname>Kundu</surname><given-names>P.</given-names></name><name><surname>Neese</surname><given-names>S.L.</given-names></name><name><surname>Bandara</surname><given-names>S.</given-names></name></person-group><article-title>The effects of the botanical estrogen, isoliquiritigenin on delayed spatial alteration</article-title><source>Neurotoxicol. Teratol.</source><volume>66</volume><year>2018</year><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">29408209</pub-id></element-citation></ref><ref id="bib0062"><element-citation publication-type="journal" id="sbref0063"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>S.H.</given-names></name><name><surname>Ma</surname><given-names>S.X.</given-names></name><name><surname>Hong</surname><given-names>S.I.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Jang</surname><given-names>C.G.</given-names></name></person-group><article-title><italic>Lonicera japonica</italic> THUNB. extract inhibits lipopolysaccharide-stimulated inflammatory responses by suppressing NF-&#x003ba;B signaling in BV-2 microglial cells</article-title><source>J. Med. Food</source><volume>18</volume><year>2015</year><fpage>762</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">25897683</pub-id></element-citation></ref><ref id="bib0063"><element-citation publication-type="journal" id="sbref0064"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>Y.J.</given-names></name><name><surname>Son</surname><given-names>D.H.</given-names></name><name><surname>Chung</surname><given-names>T.H.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name></person-group><article-title>A review of the pharmacological efficacy and safety of licorice root from corroborative clinical trial findings</article-title><source>J. Med. Food</source><volume>23</volume><year>2020</year><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">31874059</pub-id></element-citation></ref><ref id="bib0064"><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>C.</given-names></name><name><surname>Mooiman</surname><given-names>K.D.</given-names></name><name><surname>Maas-Bakker</surname><given-names>R.F.</given-names></name><name><surname>Beijnen</surname><given-names>J.H.</given-names></name><name><surname>Schellens</surname><given-names>J.H.</given-names></name><name><surname>Meijerman</surname><given-names>I</given-names></name></person-group><article-title>Effect of Chinese herbs on CYP3A4 activity and expression <italic>in vitro</italic></article-title><source>J. Ethnopharmacol.</source><volume>149</volume><year>2013</year><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">23876595</pub-id></element-citation></ref><ref id="bib0065"><element-citation publication-type="journal" id="sbref0066"><person-group person-group-type="author"><name><surname>Law</surname><given-names>A.H.</given-names></name><name><surname>Yang</surname><given-names>C.L.</given-names></name><name><surname>Lau</surname><given-names>A.S.</given-names></name><name><surname>Chan</surname><given-names>G.C.</given-names></name></person-group><article-title>Antiviral effect of forsythoside A from <italic>Forsythia suspensa</italic> (Thunb.) Vahl fruit against influenza A virus through reduction of viral M1 protein</article-title><source>J. Ethnopharmacol.</source><volume>209</volume><year>2017</year><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">28716571</pub-id></element-citation></ref><ref id="bib0066"><element-citation publication-type="journal" id="sbref0067"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Seo</surname><given-names>H.S.</given-names></name><name><surname>Ryu</surname><given-names>J.</given-names></name><name><surname>Yoon</surname><given-names>Y.P.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>C.J.</given-names></name></person-group><article-title>Luteolin inhibited the gene expression, production and secretion of MUC5AC mucin via regulation of nuclear factor kappa B signaling pathway in human airway epithelial cells</article-title><source>Pulm. Pharmacol. Ther.</source><volume>31</volume><year>2015</year><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">25285988</pub-id></element-citation></ref><ref id="bib0068"><element-citation publication-type="journal" id="sbref0069"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Ko</surname><given-names>H.J.</given-names></name><name><surname>Woo</surname><given-names>E.R.</given-names></name></person-group><article-title>Moracin M inhibits airway inflammation by interrupting the JNK/c-Jun and NF-&#x003ba;B pathways <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Eur. J. Pharmacol.</source><volume>783</volume><year>2016</year><fpage>64</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">27138708</pub-id></element-citation></ref><ref id="bib0070"><element-citation publication-type="journal" id="sbref0071"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.T.</given-names></name><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Jung</surname><given-names>W.T.</given-names></name><name><surname>Nam</surname><given-names>J.H.</given-names></name><name><surname>Jung</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>H.J.</given-names></name></person-group><article-title>Structure of a new echinocystic acid bisdesmoside isolated from <italic>Codonopsis lanceolata</italic> roots and the cytotoxic activity of prosapogenins</article-title><source>J. Agric. Food Chem.</source><volume>50</volume><year>2002</year><fpage>4190</fpage><lpage>4193</lpage><pub-id pub-id-type="pmid">12105944</pub-id></element-citation></ref><ref id="bib0071"><element-citation publication-type="journal" id="sbref0072"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M.R.</given-names></name></person-group><article-title>The history of <italic>Ephedra</italic> (<italic>ma-huang</italic>)</article-title><source>J. R. Coll. Physicians Edinb.</source><volume>41</volume><year>2011</year><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">21365072</pub-id></element-citation></ref><ref id="bib0072"><element-citation publication-type="journal" id="sbref0073"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>N.H.</given-names></name><name><surname>Yoo</surname><given-names>S.R.</given-names></name><name><surname>Kim</surname><given-names>H.G.</given-names></name><name><surname>Cho</surname><given-names>J.H.</given-names></name><name><surname>Son</surname><given-names>C.G.</given-names></name></person-group><article-title>Safety and tolerability of <italic>Panax ginseng</italic> root extract: a randomized, placebo-controlled, clinical trial in healthy Korean volunteers</article-title><source>J. Altern. Complement. Med.</source><volume>18</volume><year>2012</year><fpage>1061</fpage><lpage>1069</lpage><pub-id pub-id-type="pmid">22909282</pub-id></element-citation></ref><ref id="bib0073"><element-citation publication-type="journal" id="sbref0074"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Z.F.</given-names></name><name><surname>Li</surname><given-names>C.M.</given-names></name><name><surname>Shen</surname><given-names>J.Y.</given-names></name><name><surname>Yin</surname><given-names>H.X.</given-names></name><name><surname>Li</surname><given-names>G.S.</given-names></name></person-group><article-title>Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague-Dawley rats</article-title><source>Ginseng Res.</source><volume>44</volume><year>2020</year><fpage>222</fpage><lpage>228</lpage></element-citation></ref><ref id="bib0075"><element-citation publication-type="journal" id="sbref0076"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.Y.</given-names></name><name><surname>Xu</surname><given-names>H.X.</given-names></name><name><surname>Han</surname><given-names>Q.B.</given-names></name><name><surname>Wu</surname><given-names>T.S.</given-names></name></person-group><article-title>Quality assessment of Radix <italic>Codonopsis</italic> by quantitative nuclear magnetic resonance</article-title><source>J. Chromatogr. A</source><volume>1216</volume><year>2009</year><fpage>2124</fpage><lpage>2129</lpage><pub-id pub-id-type="pmid">19004445</pub-id></element-citation></ref><ref id="bib0076"><element-citation publication-type="journal" id="sbref0077"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name></person-group><article-title>Pharmacokinetic mechanisms underlying the detoxification effect of Glycyrhizae Radix et Rhizoma (<italic>Gancao</italic>): Drug metabolizing enzymes, transporters and beyond</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><volume>15</volume><year>2019</year><fpage>167</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">30582378</pub-id></element-citation></ref><ref id="bib0078"><element-citation publication-type="journal" id="sbref0079"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name></person-group><article-title>Honeysuckle-encoded microRNA2911 inhibits enterovirus 71 replication via targeting VP1 gene</article-title><source>Antiviral Res.</source><volume>152</volume><year>2018</year><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">29458129</pub-id></element-citation></ref><ref id="bib0082"><element-citation publication-type="journal" id="sbref0083"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Developmental toxicity research of ginsenoside Rb1 using a whole mouse embryo culture model</article-title><source>Birth Defects Res. B Dev. Reprod. Toxicol.</source><volume>74</volume><year>2005</year><fpage>207</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">15834894</pub-id></element-citation></ref><ref id="bib0083"><element-citation publication-type="journal" id="sbref0084"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)</article-title><source>Cochrane Database Syst. Rev.</source><volume>10</volume><year>2012</year><object-id pub-id-type="publisher-id">CD004882</object-id></element-citation></ref><ref id="bib0084"><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.P.</given-names></name><name><surname>Kang</surname><given-names>Y.K.</given-names></name></person-group><article-title>Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)</article-title><source>Cochrane Database Syst. Rev.</source><year>2006</year><object-id pub-id-type="publisher-id">CD004882</object-id></element-citation></ref><ref id="bib0085"><element-citation publication-type="journal" id="sbref0086"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Chronic toxicity of ginsenoside Re on Sprague-Dawley rats</article-title><source>J. Ethnopharmacol.</source><volume>144</volume><year>2012</year><fpage>656</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">23063957</pub-id></element-citation></ref><ref id="bib0086"><element-citation publication-type="journal" id="sbref0087"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>W.</given-names></name></person-group><article-title>Safety assessment of the fermented <italic>Phylloporia ribis</italic> (<italic>Lonicera japonica</italic> Thunb.) mycelia by oral acute toxicity study in mice and 90-day feeding study in rats</article-title><source>Food Chem. Toxicol.</source><volume>69</volume><year>2014</year><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">24713262</pub-id></element-citation></ref><ref id="bib0087"><element-citation publication-type="journal" id="sbref0088"><person-group person-group-type="author"><name><surname>Lu&#x000ed;s</surname><given-names>&#x000c2;.</given-names></name><name><surname>Domingues</surname><given-names>F.</given-names></name><name><surname>Pereira</surname><given-names>L.</given-names></name></person-group><article-title>Metabolic changes after licorice consumption: A systematic review with meta-analysis and trial sequential analysis of clinical trials</article-title><source>Phytomedicine</source><volume>39</volume><year>2018</year><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">29433679</pub-id></element-citation></ref><ref id="bib0088"><element-citation publication-type="journal" id="sbref0089"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Liao</surname><given-names>F.L.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>H.B.</given-names></name><name><surname>Yang</surname><given-names>Z.Q.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name></person-group><article-title>Evaluation of antibody-dependent enhancement of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine</article-title><source>Virol. Sin.</source><volume>33</volume><year>2018</year><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">29541941</pub-id></element-citation></ref><ref id="bib0089"><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>Q.L.</given-names></name><name><surname>Shang</surname><given-names>Y.X.</given-names></name></person-group><article-title>Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs</article-title><source>Chin. J. Integr. Med.</source><volume>26</volume><year>2020</year><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">32065348</pub-id></element-citation></ref><ref id="bib0091"><element-citation publication-type="journal" id="sbref0092"><person-group person-group-type="author"><name><surname>Magrone</surname><given-names>T.</given-names></name><name><surname>Magrone</surname><given-names>M.</given-names></name><name><surname>Jirillo</surname><given-names>E.</given-names></name></person-group><article-title>Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target - a perspective</article-title><source>Endocr. Metab. Immune Disord. Drug Targets</source><year>2020</year><comment>(Advance online publication)</comment></element-citation></ref><ref id="bib0092"><element-citation publication-type="journal" id="sbref0093"><person-group person-group-type="author"><name><surname>Mantani</surname><given-names>N.</given-names></name><name><surname>Andoh</surname><given-names>T.</given-names></name><name><surname>Kawamata</surname><given-names>H.</given-names></name><name><surname>Terasawa</surname><given-names>K.</given-names></name><name><surname>Ochiai</surname><given-names>H.</given-names></name></person-group><article-title>Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells</article-title><source>Antiviral Res.</source><volume>44</volume><year>1999</year><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">10651070</pub-id></element-citation></ref><ref id="bib0094"><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>T.K.</given-names></name><name><surname>Gl&#x000e1;vits</surname><given-names>R.</given-names></name><name><surname>Endres</surname><given-names>J.R.</given-names></name></person-group><article-title>A 28-day repeated dose toxicological study of an aqueous extract of <italic>Morus alba</italic> L</article-title><source>Int. J. Toxicol.</source><volume>35</volume><year>2016</year><fpage>683</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">27733446</pub-id></element-citation></ref><ref id="bib0095"><element-citation publication-type="journal" id="sbref0096"><person-group person-group-type="author"><name><surname>Mehendale</surname><given-names>S.R.</given-names></name><name><surname>Bauer</surname><given-names>B.A.</given-names></name><name><surname>Yuan</surname><given-names>C.S.</given-names></name></person-group><article-title><italic>Ephedra</italic>-containing dietary supplements in the US <italic>versus Ephedra</italic> as a Chinese medicine</article-title><source>Am. J. Chin. Med.</source><volume>32</volume><year>2004</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15154280</pub-id></element-citation></ref><ref id="bib0096"><element-citation publication-type="journal" id="sbref0097"><person-group person-group-type="author"><name><surname>Mendes-Silva</surname><given-names>W.</given-names></name><name><surname>Assafim</surname><given-names>M.</given-names></name><name><surname>Ruta</surname><given-names>B.</given-names></name><name><surname>Monteiro</surname><given-names>R.Q.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>J.A.</given-names></name><name><surname>Zingali</surname><given-names>R.B.</given-names></name></person-group><article-title>Antithrombotic effect of glycyrrhizin, a plant-derived thrombin inhibitor</article-title><source>Thromb. Res.</source><volume>112</volume><year>2003</year><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">15013279</pub-id></element-citation></ref><ref id="bib0097"><element-citation publication-type="journal" id="sbref0098"><person-group person-group-type="author"><name><surname>Michaelis</surname><given-names>M.</given-names></name><name><surname>Geiler</surname><given-names>J.</given-names></name><name><surname>Naczk</surname><given-names>P.</given-names></name></person-group><article-title>Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression</article-title><source>PLoS One</source><volume>6</volume><year>2011</year><fpage>e19705</fpage><pub-id pub-id-type="pmid">21611183</pub-id></element-citation></ref><ref id="bib0098"><element-citation publication-type="journal" id="sbref0099"><person-group person-group-type="author"><name><surname>Ming</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>F.</given-names></name></person-group><article-title>Phosphorylated <italic>Codonopsis pilosula</italic> polysaccharide could inhibit the virulence of duck hepatitis A virus compared with <italic>Codonopsis pilosula</italic> polysaccharide</article-title><source>Int. J. Biol. Macromolecules</source><volume>94</volume><year>2017</year><fpage>28</fpage><lpage>35</lpage></element-citation></ref><ref id="bib0099"><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Mirsalis</surname><given-names>J.C.</given-names></name><name><surname>Hamilton</surname><given-names>C.M.</given-names></name><name><surname>Schindler</surname><given-names>J.E.</given-names></name><name><surname>Green</surname><given-names>C.E.</given-names></name><name><surname>Dabbs</surname><given-names>J.E.</given-names></name></person-group><article-title>Effects of soya bean flakes and liquorice root extract on enzyme induction and toxicity in B6C3F1 mice</article-title><source>Food Chem. Toxicol.</source><volume>31</volume><year>1993</year><fpage>343</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">8505019</pub-id></element-citation></ref><ref id="bib0100"><element-citation publication-type="journal" id="sbref0101"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>H.N.</given-names></name><name><surname>Dandin</surname><given-names>V.S.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Paek</surname><given-names>K.Y.</given-names></name></person-group><article-title>Quality, safety and efficacy profiling of ginseng adventitious roots produced <italic>in vitro</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><volume>102</volume><year>2018</year><fpage>7309</fpage><lpage>7317</lpage><pub-id pub-id-type="pmid">29971477</pub-id></element-citation></ref><ref id="bib0101"><element-citation publication-type="journal" id="sbref0102"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>K.</given-names></name><name><surname>Hidaka</surname><given-names>T.</given-names></name><name><surname>Kitano</surname><given-names>M.</given-names></name></person-group><article-title>Genotoxicity studies on licorice flavonoid (LFO)</article-title><source>Food Chem. Toxicol.</source><volume>46</volume><year>2008</year><fpage>2525</fpage><lpage>2532</lpage><pub-id pub-id-type="pmid">18502556</pub-id></element-citation></ref><ref id="bib0102"><element-citation publication-type="book" id="sbref0103"><person-group person-group-type="author"><collab>National Library of Medicine (US)</collab></person-group><chapter-title>Licorice</chapter-title><source>Drugs and Lactation Database (LactMed)</source><year>2018</year><publisher-name>Bethesda (MD)</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30000900" id="interref0002">https://www.ncbi.nlm.nih.gov/pubmed/30000900</ext-link></element-citation></ref><ref id="bib0103"><element-citation publication-type="journal" id="sbref0104"><person-group person-group-type="author"><collab>National Toxicology Program (58 Collaborators)</collab></person-group><article-title>Toxicology and carcinogenesis studies of ginseng (CAS No. 50647-08-0) in F344/N rats and B6C3F1 mice (gavage studies)</article-title><source>Natl. Toxicol. Program Tech. Rep. Ser.</source><volume>567</volume><year>2011</year><fpage>1</fpage><lpage>149</lpage></element-citation></ref><ref id="bib0104"><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Nazari</surname><given-names>S.</given-names></name><name><surname>Rameshrad</surname><given-names>M.</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name></person-group><article-title>Toxicological effects of <italic>Glycyrrhiza glabra</italic> (Licorice): a review</article-title><source>Phytother. Res.</source><volume>31</volume><year>2017</year><fpage>1635</fpage><lpage>1650</lpage><pub-id pub-id-type="pmid">28833680</pub-id></element-citation></ref><ref id="bib0105"><element-citation publication-type="journal" id="sbref0106"><person-group person-group-type="author"><name><surname>Nishimoto</surname><given-names>Y.</given-names></name><name><surname>Hisatsune</surname><given-names>A.</given-names></name><name><surname>Katsuki</surname><given-names>H.</given-names></name><name><surname>Miyata</surname><given-names>T.</given-names></name><name><surname>Yokomizo</surname><given-names>K.</given-names></name><name><surname>Isohama</surname><given-names>Y.</given-names></name></person-group><article-title>Glycyrrhizin attenuates mucus production by inhibition of <italic>MUC5AC</italic> mRNA expression <italic>in vivo</italic> and <italic>in vitro</italic></article-title><source>J. Pharmacol. Sci.</source><volume>113</volume><year>2010</year><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">20453436</pub-id></element-citation></ref><ref id="bib0106"><element-citation publication-type="book" id="sbref0107"><person-group person-group-type="author"><name><surname>Oesch-Bartlomowicz</surname><given-names>B.</given-names></name><name><surname>Oesch</surname><given-names>F.</given-names></name></person-group><chapter-title>Mechanisms of toxication and detoxication which challenge drug candidates and drugs</chapter-title><person-group person-group-type="editor"><name><surname>Taylor</surname></name><name><surname>Triggle</surname></name></person-group><source>Comprehensive Medicinal Chemistry</source><year>2007</year><publisher-name>Elsevier Amsterdam</publisher-name><fpage>193</fpage><lpage>214</lpage></element-citation></ref><ref id="bib0107"><element-citation publication-type="journal" id="sbref0108"><person-group person-group-type="author"><name><surname>Oesch-Bartlomowicz</surname><given-names>B.</given-names></name><name><surname>Richter</surname><given-names>B.</given-names></name><name><surname>Becker</surname><given-names>R.</given-names></name></person-group><article-title>cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal control <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Int. J. Cancer</source><volume>94</volume><year>2001</year><fpage>733</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">11745470</pub-id></element-citation></ref><ref id="bib0108"><element-citation publication-type="journal" id="sbref0109"><person-group person-group-type="author"><name><surname>Olukoga</surname><given-names>A.</given-names></name><name><surname>Donaldson</surname><given-names>D.</given-names></name></person-group><article-title>Liquorice and its health implications</article-title><source>J. R. Soc. Promot. Health</source><volume>120</volume><year>2000</year><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">10944880</pub-id></element-citation></ref><ref id="bib0109"><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Omar</surname><given-names>H.R.</given-names></name><name><surname>Komarova</surname><given-names>I.</given-names></name><name><surname>El-Ghonemi</surname><given-names>M.</given-names></name></person-group><article-title>Licorice abuse: time to send a warning message</article-title><source>Ther. Adv. Endocrinol. Metab.</source><volume>3</volume><year>2012</year><fpage>125</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">23185686</pub-id></element-citation></ref><ref id="bib0110"><element-citation publication-type="journal" id="sbref0111"><person-group person-group-type="author"><name><surname>Ouedraogo</surname><given-names>M.</given-names></name><name><surname>Baudoux</surname><given-names>T.</given-names></name><name><surname>St&#x000e9;vigny</surname><given-names>C.</given-names></name><name><surname>Nortier</surname><given-names>J.</given-names></name><name><surname>Colet</surname><given-names>J.M.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Qu</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>K.</given-names></name><name><surname>Shaw</surname><given-names>D.</given-names></name><name><surname>Pelkonen</surname><given-names>O.</given-names></name><name><surname>Duez</surname><given-names>P.</given-names></name></person-group><article-title>Review of current and "omics" methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms</article-title><source>J. Ethnopharmacol.</source><volume>140</volume><year>2012</year><fpage>492</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">22386524</pub-id></element-citation></ref><ref id="bib0111"><element-citation publication-type="journal" id="sbref0112"><person-group person-group-type="author"><name><surname>Paik</surname><given-names>D.J.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name></person-group><article-title>Review of cases of patient risk associated with ginseng abuse and misuse</article-title><source>J. Ginseng Res.</source><volume>39</volume><year>2015</year><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">26045681</pub-id></element-citation></ref><ref id="bib0112"><element-citation publication-type="journal" id="sbref0113"><person-group person-group-type="author"><name><surname>Park</surname><given-names>I.D.</given-names></name><name><surname>Yoo</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>Y.W.</given-names></name></person-group><article-title>Toxicological study on MUNOPHIL, water extract of <italic>Panax ginseng</italic> and <italic>Hericium erinaceum</italic> in rats</article-title><source>J. Acupunct. Meridian Stud.</source><volume>1</volume><year>2008</year><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">20633464</pub-id></element-citation></ref><ref id="bib0113"><element-citation publication-type="journal" id="sbref0114"><person-group person-group-type="author"><name><surname>Park</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>Y.H.</given-names></name><name><surname>Choi</surname><given-names>E.K.</given-names></name></person-group><article-title>Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA</article-title><source>Birth Defects Res. B Dev. Reprod. Toxicol.</source><volume>92</volume><year>2011</year><fpage>553</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">21818843</pub-id></element-citation></ref><ref id="bib0114"><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Noh</surname><given-names>J.</given-names></name><name><surname>Jeong</surname><given-names>E.J.</given-names></name></person-group><article-title>Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>92</volume><year>2018</year><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">29155077</pub-id></element-citation></ref><ref id="bib0115"><element-citation publication-type="journal" id="sbref0116"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Lim</surname><given-names>K.H.</given-names></name><name><surname>Noh</surname><given-names>J.H.</given-names></name></person-group><article-title>Subacute oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats</article-title><source>Toxicol. Res.</source><volume>29</volume><year>2013</year><fpage>285</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">24578799</pub-id></element-citation></ref><ref id="bib0116"><element-citation publication-type="journal" id="sbref0117"><person-group person-group-type="author"><name><surname>Pastorino</surname><given-names>G.</given-names></name><name><surname>Cornara</surname><given-names>L.</given-names></name><name><surname>Soares</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>F.</given-names></name><name><surname>Oliveira</surname><given-names>M.</given-names></name></person-group><article-title>Liquorice (<italic>Glycyrrhiza glabra</italic>): a phytochemical and pharmacological review</article-title><source>Phytother. Res.</source><volume>32</volume><year>2018</year><fpage>2323</fpage><lpage>2339</lpage><pub-id pub-id-type="pmid">30117204</pub-id></element-citation></ref><ref id="bib0117"><element-citation publication-type="journal" id="sbref0118"><person-group person-group-type="author"><name><surname>Pilcher</surname><given-names>H.</given-names></name></person-group><article-title>Liquorice may tackle SARS</article-title><source>Nature</source><year>2003</year><pub-id pub-id-type="doi">10.1038/news030609-16</pub-id></element-citation></ref><ref id="bib0118"><element-citation publication-type="journal" id="sbref0119"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name></person-group><article-title>Characterization, crystal structure and cytotoxic activity of a rare iridoid glycoside from <italic>Lonicera saccata</italic></article-title><source>Acta Crystallogr. C Struct. Chem.</source><volume>76</volume><year>2020</year><fpage>269</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">32132285</pub-id></element-citation></ref><ref id="bib0119"><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>A.</given-names></name><name><surname>Kamochi</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>H.</given-names></name></person-group><article-title>De novo transcriptome assembly and characterization of nine tissues of <italic>Lonicera japonica</italic> to identify potential candidate genes involved in chlorogenic acid, luteolosides, and secoiridoid biosynthesis pathways</article-title><source>J. Nat. Med.</source><volume>71</volume><year>2017</year><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">27629269</pub-id></element-citation></ref><ref id="bib0120"><element-citation publication-type="journal" id="sbref0121"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>X.</given-names></name><name><surname>Shao</surname><given-names>X.X.</given-names></name><name><surname>Li</surname><given-names>X.X.</given-names></name></person-group><article-title>Identifying potential treatments of COVID-19 from traditional Chinese medicine (TCM) by using a data-driven approach</article-title><source>J. Ethnopharmacol.</source><volume>258</volume><year>2020</year><object-id pub-id-type="publisher-id">112932</object-id></element-citation></ref><ref id="bib0121"><element-citation publication-type="journal" id="sbref0122"><person-group person-group-type="author"><name><surname>Samenuk</surname><given-names>D.</given-names></name><name><surname>Link</surname><given-names>M.S.</given-names></name><name><surname>Homoud</surname><given-names>M.K.</given-names></name></person-group><article-title>Adverse cardiovascular events temporally associated with <italic>ma huang</italic>, an herbal source of ephedrine</article-title><source>Mayo Clin. Proc.</source><volume>77</volume><year>2002</year><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">11795249</pub-id></element-citation></ref><ref id="bib0122"><element-citation publication-type="journal" id="sbref0123"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>J.M.</given-names></name><name><surname>Monogue</surname><given-names>M.L.</given-names></name><name><surname>Jodlowski</surname><given-names>T.Z.</given-names></name><name><surname>Cutrell</surname><given-names>J.B.</given-names></name></person-group><article-title>Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review</article-title><source>JAMA</source><volume>323</volume><year>2020</year><fpage>1824</fpage><lpage>1836</lpage><pub-id pub-id-type="pmid">32282022</pub-id></element-citation></ref><ref id="bib0123"><element-citation publication-type="journal" id="sbref0124"><person-group person-group-type="author"><name><surname>Seely</surname><given-names>D.</given-names></name><name><surname>Dugoua</surname><given-names>J.J.</given-names></name><name><surname>Perri</surname><given-names>D.</given-names></name><name><surname>Mills</surname><given-names>E.</given-names></name><name><surname>Koren</surname><given-names>G.</given-names></name></person-group><article-title>Safety and efficacy of <italic>Panax ginseng</italic> during pregnancy and lactation</article-title><source>Can. J. Clin. Pharmacol.</source><volume>15</volume><year>2008</year><fpage>e87</fpage><lpage>e94</lpage><pub-id pub-id-type="pmid">18204104</pub-id></element-citation></ref><ref id="bib0124"><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>H.W.</given-names></name><name><surname>Suh</surname><given-names>J.H.</given-names></name><name><surname>Kyung</surname><given-names>J.S.</given-names></name><name><surname>Jang</surname><given-names>K.H.</given-names></name><name><surname>So</surname><given-names>S.H.</given-names></name></person-group><article-title>Subacute oral toxicity and bacterial mutagenicity study of a mixture of Korean red ginseng (<italic>Panax ginseng</italic> C.A. Meyer) and <italic>Salvia plebeia</italic> R. Br. extracts</article-title><source>Toxicol. Res.</source><volume>35</volume><year>2019</year><fpage>215</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">31341550</pub-id></element-citation></ref><ref id="bib0126"><element-citation publication-type="journal" id="sbref0127"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Miao</surname><given-names>X.</given-names></name><name><surname>Ding</surname><given-names>H.</given-names></name></person-group><article-title><italic>Lonicera japonica</italic> Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine</article-title><source>J. Ethnopharmacol.</source><volume>138</volume><year>2011</year><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">21864666</pub-id></element-citation></ref><ref id="bib0127"><element-citation publication-type="journal" id="sbref0128"><person-group person-group-type="author"><name><surname>Shergis</surname><given-names>J.L.</given-names></name><name><surname>Zhang</surname><given-names>A.L.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Xue</surname><given-names>C.C.</given-names></name></person-group><article-title>Quality and risk of bias in <italic>Panax ginseng</italic> randomized controlled trials: a review</article-title><source>Am. J. Chin. Med.</source><volume>41</volume><year>2013</year><fpage>231</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">23548116</pub-id></element-citation></ref><ref id="bib0128"><element-citation publication-type="journal" id="sbref0129"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>S.</given-names></name><name><surname>Jang</surname><given-names>J.Y.</given-names></name><name><surname>Choi</surname><given-names>B.I.</given-names></name></person-group><article-title>Licorice extract does not impair the male reproductive function of rats</article-title><source>Exp. Anim.</source><volume>57</volume><year>2008</year><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">18256514</pub-id></element-citation></ref><ref id="bib0129"><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>S.</given-names></name><name><surname>Yi</surname><given-names>J.M.</given-names></name><name><surname>Kim</surname><given-names>N.S.</given-names></name><name><surname>Park</surname><given-names>Chan-Sung</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Bang</surname><given-names>Ok-Sun</given-names></name></person-group><article-title>Aqueous extract of <italic>Forsythia viridissima</italic> fruits: Acute oral toxicity and genotoxicity studies</article-title><source>J. Ethnopharmacol.</source><volume>249</volume><year>2020</year><object-id pub-id-type="publisher-id">112381</object-id></element-citation></ref><ref id="bib0130"><element-citation publication-type="journal" id="sbref0131"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>W.H.</given-names></name><name><surname>Ri</surname><given-names>Y.</given-names></name><name><surname>Do</surname><given-names>S.G.</given-names></name><name><surname>Lee</surname><given-names>Y.C.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name></person-group><article-title>13-week subchronic toxicity study of a novel ginsenoside composition from ginseng leaves in rats</article-title><source>Lab. Anim. Res.</source><volume>30</volume><year>2014</year><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">25324872</pub-id></element-citation></ref><ref id="bib0132"><element-citation publication-type="journal" id="sbref0133"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>Y.K.</given-names></name><name><surname>Han</surname><given-names>A.Y.</given-names></name><name><surname>Hsieh</surname><given-names>Y.S.</given-names></name></person-group><article-title>Lancemaside A from <italic>Codonopsis lanceolata</italic> prevents hypertension by inhibiting NADPH oxidase 2-mediated MAPK signalling and improving NO bioavailability in rats</article-title><source>J. Pharm. Pharmacol.</source><volume>71</volume><year>2019</year><fpage>1458</fpage><lpage>1468</lpage><pub-id pub-id-type="pmid">31350796</pub-id></element-citation></ref><ref id="bib0133"><element-citation publication-type="journal" id="sbref0134"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q.L.</given-names></name><name><surname>Li</surname><given-names>Y.X.</given-names></name><name><surname>Cui</surname><given-names>Y.S.</given-names></name><name><surname>Jiang</surname><given-names>S.L.</given-names></name><name><surname>Dong</surname><given-names>C.X.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name></person-group><article-title>Structural characterization of three polysaccharides from the roots of <italic>Codonopsis pilosula</italic> and their immunomodulatory effects on RAW264.7 macrophages</article-title><source>Int. J. Biol. Macromol.</source><volume>130</volume><year>2019</year><fpage>556</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">30831168</pub-id></element-citation></ref><ref id="bib0135"><element-citation publication-type="journal" id="sbref0136"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name></person-group><article-title>Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia</article-title><source>J. Thromb. Haemost.</source><volume>18</volume><year>2020</year><fpage>844</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">32073213</pub-id></element-citation></ref><ref id="bib0136"><element-citation publication-type="journal" id="sbref0137"><person-group person-group-type="author"><name><surname>Thabti</surname><given-names>I.</given-names></name><name><surname>Albert</surname><given-names>Q.</given-names></name><name><surname>Philippot</surname><given-names>S.</given-names></name></person-group><article-title>Advances on antiviral activity of <italic>Morus</italic> spp. plant extracts: Human coronavirus and virus-related respiratory tract infections in the spotlight</article-title><source>Molecules</source><volume>25</volume><year>2020</year><fpage>1876</fpage></element-citation></ref><ref id="bib0137"><element-citation publication-type="journal" id="sbref0138"><person-group person-group-type="author"><name><surname>Thanabhorn</surname><given-names>S.</given-names></name><name><surname>Jaijoy</surname><given-names>K.</given-names></name><name><surname>Thamaree</surname><given-names>S.</given-names></name><name><surname>Ingkaninan</surname><given-names>K.</given-names></name><name><surname>Panthong</surname><given-names>A.</given-names></name></person-group><article-title>Acute and subacute toxicity study of the ethanol extract from Lonicera japonica</article-title><source>Thunb. J. Ethnopharmacol.</source><volume>107</volume><year>2006</year><fpage>370</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">16697541</pub-id></element-citation></ref><ref id="bib0138"><element-citation publication-type="journal" id="sbref0139"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>T.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group><article-title>Glycyrrhizic-acid-based carbon dots with high antiviral activity by multisite inhibition mechanisms</article-title><source>Small</source><volume>16</volume><year>2020</year><object-id pub-id-type="publisher-id">1906206</object-id></element-citation></ref><ref id="bib0139"><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>C.T.</given-names></name><name><surname>Sbrana</surname><given-names>E</given-names></name><name><surname>Iwata-Yoshikawa</surname><given-names>N.</given-names></name></person-group><article-title>Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus</article-title><source>PLoS One</source><volume>7</volume><year>2012</year><fpage>e35421</fpage><pub-id pub-id-type="pmid">22536382</pub-id></element-citation></ref><ref id="bib0140"><element-citation publication-type="journal" id="sbref0141"><person-group person-group-type="author"><name><surname>Utsunomiya</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Pollard</surname><given-names>R.B.</given-names></name><name><surname>Suzuki</surname><given-names>F.</given-names></name></person-group><article-title>Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus</article-title><source>Antimicrob. Agents Chemother.</source><volume>41</volume><year>1997</year><fpage>551</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">9055991</pub-id></element-citation></ref><ref id="bib0141"><element-citation publication-type="journal" id="sbref0142"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name></person-group><article-title>A comprehensive review for phytochemical, pharmacological, and biosynthesis studies on <italic>Glycyrrhiza</italic> spp</article-title><source>Am. J. Chin. Med.</source><volume>48</volume><year>2020</year><fpage>17</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">31931596</pub-id></element-citation></ref><ref id="bib0142"><element-citation publication-type="journal" id="sbref0143"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>P.</given-names></name></person-group><article-title>Traditional Chinese medicine for the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials</article-title><source>J. Tradit. Chin. Med.</source><volume>34</volume><year>2014</year><fpage>527</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">25417400</pub-id></element-citation></ref><ref id="bib0145"><element-citation publication-type="journal" id="sbref0146"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name></person-group><article-title>Liquorice, a unique &#x0201c;guide drug&#x0201d; of traditional Chinese medicine: A review of its role in drug interactions</article-title><source>J. Ethnopharmacol.</source><volume>150</volume><year>2013</year><fpage>781</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">24201019</pub-id></element-citation></ref><ref id="bib0146"><element-citation publication-type="journal" id="sbref0147"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>Y.J.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name></person-group><article-title>Antiviral activity of fermented ginseng extracts against a broad range of influenza viruses</article-title><source>Viruses</source><volume>10</volume><year>2018</year><fpage>471</fpage></element-citation></ref><ref id="bib0148"><element-citation publication-type="journal" id="sbref0149"><person-group person-group-type="author"><name><surname>Wattanathorn</surname><given-names>J.</given-names></name><name><surname>Somboonporn</surname><given-names>W.</given-names></name><name><surname>Sungkamanee</surname><given-names>S.</given-names></name><name><surname>Thukummee</surname><given-names>W.</given-names></name><name><surname>Muchimapura</surname><given-names>S.</given-names></name></person-group><article-title>A double-blind placebo-controlled randomized trial evaluating the effect of polyphenol-rich herbal congee on bone turnover markers of the perimenopausal and menopausal women</article-title><source>Oxid. Med. Cell Longev.</source><volume>2018</volume><year>2018</year><object-id pub-id-type="publisher-id">2091872</object-id></element-citation></ref><ref id="bib0149"><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Shao</surname><given-names>C.</given-names></name></person-group><article-title>Screening of antiviral components of <italic>ma huang tang</italic> and investigation on the <italic>Ephedra</italic> alkaloids efficacy on influenza virus type A</article-title><source>Front. Pharmacol.</source><volume>10</volume><year>2019</year><fpage>961</fpage><pub-id pub-id-type="pmid">31551774</pub-id></element-citation></ref><ref id="bib0150"><element-citation publication-type="journal" id="sbref0151"><person-group person-group-type="author"><name><surname>Wongwat</surname><given-names>T.</given-names></name><name><surname>Srihaphon</surname><given-names>K.</given-names></name><name><surname>Pitaksutheepong</surname><given-names>C.</given-names></name><name><surname>Boonyo</surname><given-names>W.</given-names></name><name><surname>Pitaksuteepong</surname><given-names>T.</given-names></name></person-group><article-title>Suppression of inflammatory mediators and matrix metalloproteinase (MMP)-13 by <italic>Morus alba</italic> stem extract and oxyresveratrol in RAW 264.7&#x0202f;cells and C28/I2 human chondrocytes</article-title><source>J. Tradit. Complement. Med.</source><volume>10</volume><year>2020</year><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">32257876</pub-id></element-citation></ref><ref id="bib0151"><element-citation publication-type="journal" id="sbref0152"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Choi</surname><given-names>E.S.</given-names></name></person-group><article-title>Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalzed patients in a single medical center</article-title><source>Phytomedicine</source><volume>22</volume><year>2015</year><fpage>1201</fpage><lpage>1205</lpage><pub-id pub-id-type="pmid">26598920</pub-id></element-citation></ref><ref id="bib0152"><element-citation publication-type="journal" id="sbref0153"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>A.D.</given-names></name><name><surname>Watson</surname><given-names>W.A.</given-names></name><name><surname>Smolinske</surname><given-names>S.</given-names></name><name><surname>Litovitz</surname><given-names>T.</given-names></name></person-group><article-title>The severity of toxic reactions to <italic>Ephedra</italic>: comparisons to other botanical products and national trends from 1993-2002</article-title><source>Clin. Toxicol. (Phila)</source><volume>43</volume><year>2005</year><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">16235509</pub-id></element-citation></ref><ref id="bib0153"><element-citation publication-type="journal" id="sbref0154"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.T.</given-names></name><name><surname>Chiu</surname><given-names>C.Y.</given-names></name><name><surname>Huang</surname><given-names>C.F.</given-names></name><name><surname>Peng</surname><given-names>F.C.</given-names></name><name><surname>Liu</surname><given-names>S.H.</given-names></name></person-group><article-title>Genotoxicity and 28-day oral toxicity studies of a functional food mixture containing maltodextrin, white kidney bean extract, mulberry leaf extract, and niacin-bound chromium complex</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>92</volume><year>2018</year><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">29155076</pub-id></element-citation></ref><ref id="bib0154"><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Friedemann</surname><given-names>T.</given-names></name><name><surname>Tao</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Ling</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>R.</given-names></name><name><surname>Geng</surname><given-names>Z.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>S.</given-names></name></person-group><article-title>Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study</article-title><source>Phytomedicine</source><volume>153390</volume><year>2020</year></element-citation></ref><ref id="bib0155"><element-citation publication-type="journal" id="sbref0156"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>K.L.</given-names></name><name><surname>Liu</surname><given-names>R.X.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>Z.P.</given-names></name><name><surname>Zhang</surname><given-names>S.M.</given-names></name><name><surname>Dai</surname><given-names>S.J.</given-names></name></person-group><article-title>Labdane diterpenoids from <italic>Forsythia suspensa</italic> with anti-inflammatory and anti-viral activities</article-title><source>Phytochemistry</source><volume>173</volume><year>2020</year><object-id pub-id-type="publisher-id">112298</object-id></element-citation></ref><ref id="bib0156"><element-citation publication-type="journal" id="sbref0157"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Oliverson</surname><given-names>B.G.</given-names></name><name><surname>Simmons</surname><given-names>D.L.</given-names></name></person-group><article-title>Trifunctional inhibition of COX-2 by extracts of <italic>Lonicera japonica</italic>: direct inhibition, transcriptional and post-transcriptional down regulation</article-title><source>J. Ethnopharmacol.</source><volume>111</volume><year>2007</year><fpage>667</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">17314019</pub-id></element-citation></ref><ref id="bib0157"><element-citation publication-type="journal" id="sbref0158"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Islam</surname><given-names>M.S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective</article-title><source>Int. J. Biol. Sci.</source><volume>16</volume><year>2020</year><fpage>1708</fpage><lpage>1717</lpage><pub-id pub-id-type="pmid">32226288</pub-id></element-citation></ref><ref id="bib0159"><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Yiemwattana</surname><given-names>I.</given-names></name><name><surname>Kaomongkolgit</surname><given-names>R.</given-names></name><name><surname>Wirojchanasak</surname><given-names>S.</given-names></name><name><surname>Chaisomboon</surname><given-names>N.</given-names></name></person-group><article-title><italic>Morus alba</italic> stem extract suppresses matrix metalloproteinases (MMP)-1, MMP-9, and tissue inhibitors of metalloproteinase (TIMP)-1 expression via inhibition of I&#x003ba;B&#x003b1; degradation induced by <italic>Porphyromonas gingivalis</italic> LPS signal in THP-1 cells</article-title><source>Eur. J. Dent.</source><volume>13</volume><year>2019</year><fpage>229</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">31569263</pub-id></element-citation></ref><ref id="bib0160"><element-citation publication-type="journal" id="sbref0161"><person-group person-group-type="author"><name><surname>Yimam</surname><given-names>M.</given-names></name><name><surname>Jiao</surname><given-names>P.</given-names></name><name><surname>Hong</surname><given-names>M.</given-names></name></person-group><article-title>Repeated dose 28-day oral toxicity study of a botanical composition composed of <italic>Morus alba</italic> L. and <italic>Acacia catechu</italic> in rats</article-title><source>Regul. Toxicol. Pharmacol.</source><volume>94</volume><year>2018</year><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">29407201</pub-id></element-citation></ref><ref id="bib0189"><element-citation publication-type="journal" id="sbref0162"><person-group person-group-type="author"><name><surname>Youns</surname><given-names>M</given-names></name><name><surname>Hoheisel</surname><given-names>J.D.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours</article-title><source>Curr. Drug Discov. Technol.</source><volume>7</volume><year>2010</year><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">20156142</pub-id></element-citation></ref><ref id="bib0161"><element-citation publication-type="journal" id="sbref0163"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.Q.</given-names></name><name><surname>Chen</surname><given-names>R.Y.</given-names></name><name><surname>Huang</surname><given-names>L.J.</given-names></name></person-group><article-title>The structure and absolute configuration of <italic>Shuangkangsu</italic>: a novel natural cyclic peroxide from <italic>Lonicera japonica</italic> (Thunb.)</article-title><source>J. Asian Nat. Prod. Res.</source><volume>10</volume><year>2008</year><fpage>851</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">18985497</pub-id></element-citation></ref><ref id="bib0162"><element-citation publication-type="journal" id="sbref0164"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Lan</surname><given-names>R.</given-names></name><name><surname>Shen</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><object-id pub-id-type="publisher-id">106012</object-id></element-citation></ref><ref id="bib0163"><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.L.</given-names></name><name><surname>Li</surname><given-names>W.X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wong</surname><given-names>M.S.</given-names></name><name><surname>Wang</surname><given-names>Y.J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism</article-title><source>Phytomedicine</source><volume>153297</volume><year>2020</year></element-citation></ref><ref id="bib0165"><element-citation publication-type="journal" id="sbref0167"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Tu</surname><given-names>D.</given-names></name><name><surname>Ge</surname><given-names>G.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19</article-title><source>Phytomedicine</source><volume>153315</volume><year>2020</year></element-citation></ref><ref id="bib0166"><element-citation publication-type="journal" id="sbref0168"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Xiang</surname><given-names>K.L.</given-names></name><name><surname>Liu</surname><given-names>R.X.</given-names></name><name><surname>Xie</surname><given-names>Z.P.</given-names></name><name><surname>Zhang</surname><given-names>S.M.</given-names></name><name><surname>Dai</surname><given-names>S.J.</given-names></name></person-group><article-title>Anti-inflammatory and anti-viral labdane diterpenoids from the fruits of <italic>Forsythia suspensa</italic></article-title><source>Bioorg. Chem.</source><volume>96</volume><year>2020</year><object-id pub-id-type="publisher-id">103651</object-id></element-citation></ref><ref id="bib0168"><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Baak</surname><given-names>J.P.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Gan</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>C.</given-names></name></person-group><article-title>Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW</article-title><source>Phytomedicine</source><volume>79</volume><year>2020</year><object-id pub-id-type="publisher-id">153336</object-id></element-citation></ref><ref id="bib0169"><element-citation publication-type="journal" id="sbref0171"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>S.S.</given-names></name></person-group><article-title>Effect of forsythiaside A on the RLRs signaling pathway in the lungs of mice infected with the influenza A virus FM1 strain</article-title><source>Molecules</source><volume>24</volume><year>2019</year><fpage>4219</fpage></element-citation></ref></ref-list></back></article>